"doc1","doc2","distance"
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.74588833661779
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Plans with Low Enrollment",0.732508532105821
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Part C Cost Sharing Standards",0.708621854787613
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section I Validation Audits",0.697679906405894
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section B.  Encounter Data as a Diagnosis Source for 2019",0.696234336709572
"Section I Plan Corrections","Section I Incomplete and Inaccurate Bid Submissions",0.678247857576012
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section N.  Encounter Data as a Diagnosis Source for 2019",0.662808592449074
"Section II Maximum Out of Pocket (MOOP) Limits","Section II Part C Cost Sharing Standards",0.634924435285066
"Section II Tiered Cost Sharing of Medical Benefits","Section III Improving Access to Part D Vaccines",0.621353489581761
"Section II Tiered Cost Sharing of Medical Benefits","Section II Part C Cost Sharing Standards",0.616316004539352
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Improving Access to Part D Vaccines",0.596920001235307
"Section II Cost Plan Competition Requirements","Section II Cost Plan Transition to MA under MACRA",0.592693416752324
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.561452067575322
"Section III Tier Composition","Section III Improving Access to Part D Vaccines",0.553665842281027
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section III Improving Access to Part D Vaccines",0.551223284646257
"Section III Improving Access to Part D Vaccines","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.542185914463853
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Health Related Supplemental Benefits",0.529308306727901
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Part C Cost Sharing Standards",0.528964714619482
"Section II Tiered Cost Sharing of Medical Benefits","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.528763750702369
"Section D.  ESRD Rates","Section B.  Calculation of Fee for Service Cost",0.528124474301917
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.523710185073579
"Section II Outpatient Observation Services","Section II Part C Cost Sharing Standards",0.52346312931061
"Section III Benefit Review","Section III Improving Access to Part D Vaccines",0.516352648375757
"Section III Improving Access to Part D Vaccines","Section II Part C Cost Sharing Standards",0.510663361695463
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Incomplete and Inaccurate Bid Submissions",0.501711973679461
"Section III Benefit Review","Section II Tiered Cost Sharing of Medical Benefits",0.498676618313859
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Maximum Out of Pocket (MOOP) Limits",0.498500687674151
"Section II Part C Optional Supplemental Benefits","Section II Health Related Supplemental Benefits",0.497218365487837
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.49672714068489
"Section III Benefit Review","Section II Part C Cost Sharing Standards",0.496469411275884
"Section A.  MA Growth Percentage","Section B.  FFS Growth Percentage",0.482616555492202
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.481829795181151
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Improving Access to Part D Vaccines",0.476642348507763
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.474529318902098
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Health Related Supplemental Benefits",0.471518743318039
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section D.  Retiree Drug Subsidy Amounts",0.469632317070961
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.461945832469213
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Part C Cost Sharing Standards",0.461233676372684
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.459317272957614
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.458479321407397
"Section III Benefit Review","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.456837421852433
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.456188504195387
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Part C Cost Sharing Standards",0.45526856369837
"Section C.  IME Phase Out","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.453157522861977
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Medicare Advantage (MA) Uniformity Flexibility",0.443312992423365
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Part C Cost Sharing Standards",0.43785800119929
"Section II Cost Plan Competition Requirements","Section D.  Retiree Drug Subsidy Amounts",0.436851715443981
"Section III Specialty Tiers","Section III Tier Composition",0.435872526697984
"Section II Tiered Cost Sharing of Medical Benefits","Section II Maximum Out of Pocket (MOOP) Limits",0.432243196789905
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Health Related Supplemental Benefits",0.431041597034859
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Medicare Advantage (MA) Uniformity Flexibility",0.423933442851413
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.418985449763654
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section G.  MA Employer Group Waiver Plans",0.418974679352636
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Health Related Supplemental Benefits",0.418097409113371
"Section III Benefit Review","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.411178339715044
"Section II Cost Plan Competition Requirements","Section II Part C Cost Sharing Standards",0.411086483895919
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Total Beneficiary Cost (TBC)",0.407524301799466
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.406877692650912
"Section II Tiered Cost Sharing of Medical Benefits","Section III Tier Composition",0.406128691055944
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Improving Access to Part D Vaccines",0.405995823655219
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.405985695694593
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.405897807243204
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.404818037239011
"Section II Outpatient Observation Services","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.402724324372814
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Part C Cost Sharing Standards",0.401247330236514
"Section III Benefit Review","Section III Tier Composition",0.396635722672666
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.393988283665367
"Section A.  Update of the RxHCC Model","Section L.  Normalization Factors",0.392189899359521
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Medicare Advantage (MA) Uniformity Flexibility",0.39172499625515
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Part C Cost Sharing Standards",0.38995560283512
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Tiered Cost Sharing of Medical Benefits",0.38253717708635
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Plan Corrections",0.382336913454289
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Tiered Cost Sharing of Medical Benefits",0.381100601893849
"Section III Improving Access to Part D Vaccines","Section II Maximum Out of Pocket (MOOP) Limits",0.380316201087262
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section L.  Normalization Factors",0.37864292631538
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Part C Cost Sharing Standards",0.377803076021517
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.375545033906552
"Section III Specialty Tiers","Section III Improving Access to Part D Vaccines",0.374087936477194
"Section D.  ESRD Rates","Section I.  ESRD Risk Adjustment Model for CY 2019",0.374058926871217
"Section II Part C Optional Supplemental Benefits","Section II Medicare Advantage (MA) Uniformity Flexibility",0.372931917084951
"Section A.  Update of the RxHCC Model","Section I.  ESRD Risk Adjustment Model for CY 2019",0.369140456480438
"Section B.  FFS Growth Percentage","Section D.  ESRD Rates",0.368754609461428
"Section D.  Retiree Drug Subsidy Amounts","Section II Cost Plan Transition to MA under MACRA",0.367990036096994
"Section I Annual Calendar","Section IV   Medicare Medicaid Plans",0.36577066147439
"Section II Outpatient Observation Services","Section II Tiered Cost Sharing of Medical Benefits",0.362400763501364
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Tiered Cost Sharing of Medical Benefits",0.361465946229727
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section L.  Normalization Factors",0.361422603010851
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section L.  Normalization Factors",0.360779244093954
"Section II Part C Cost Sharing Standards","Section E.  Clinical Trials",0.358677159486671
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.358038200304142
"Section II Cost Plan Competition Requirements","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.357622320274923
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.357490184050126
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.356899392767072
"Section II Cost Plan Competition Requirements","Section II Overview of CY 2019 Benefits and Bid Review",0.355905204582361
"Section II Employer Group Waiver Plans","Section I Incomplete and Inaccurate Bid Submissions",0.355764471694309
"Section III Expanding the Part D OTC Program","Section III CY 2019 Formulary Submission Window",0.353223672736903
"Section II Cost Plan Competition Requirements","Section II Tiered Cost Sharing of Medical Benefits",0.351129136660574
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.350635850811649
"Section II Cost Plan Competition Requirements","Section II Medicare Advantage (MA) Uniformity Flexibility",0.350441277673819
"Section I Annual Calendar","Section I Incomplete and Inaccurate Bid Submissions",0.349831751720251
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.348114603766498
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section B.  Calculation of Fee for Service Cost",0.347333963675135
"Section G.  MA Employer Group Waiver Plans","Section B.  Calculation of Fee for Service Cost",0.346550583619923
"Section D.  Retiree Drug Subsidy Amounts","Section II Part C Cost Sharing Standards",0.345824140297126
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Maximum Out of Pocket (MOOP) Limits",0.343005842569003
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Health Related Supplemental Benefits",0.342417471768742
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Medicare Advantage (MA) Uniformity Flexibility",0.342182681663756
"Section II Part C Optional Supplemental Benefits","Section II Medicare Advantage (MA) Segmented Service Area Options",0.341611643343844
"Section III Benefit Review","Section II Maximum Out of Pocket (MOOP) Limits",0.340121862715627
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Tiered Cost Sharing of Medical Benefits",0.340022206256963
"Section III CY 2019 Formulary Submission Window","Section IV   Medicare Medicaid Plans",0.335373935619947
"Section II Tiered Cost Sharing of Medical Benefits","Section E.  Clinical Trials",0.334197010258651
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.332176499282523
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.331754445460472
"Section C.  IME Phase Out","Section B.  Calculation of Fee for Service Cost",0.331129901070069
"Section II Part C Optional Supplemental Benefits","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.330709967772693
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.32912615246665
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.327702579458043
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Cost Plan Competition Requirements",0.327239314404741
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section G.  MA Employer Group Waiver Plans",0.32713976109035
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.325257865873741
"Section II Part C Optional Supplemental Benefits","Section II Overview of CY 2019 Benefits and Bid Review",0.325060470473898
"Section III Benefit Review","Section II Overview of CY 2019 Benefits and Bid Review",0.324902468378682
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Tier Composition",0.324690416244008
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Cost Plan Transition to MA under MACRA",0.324346083187988
"Section B.  FFS Growth Percentage","Section B.  Calculation of Fee for Service Cost",0.322432061352812
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Improving Access to Part D Vaccines",0.321907114004745
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Validation Audits",0.320859247079426
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.319225116145572
"Section D.  Retiree Drug Subsidy Amounts","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.318887741988298
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Part C Cost Sharing Standards",0.318370766000157
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section A.  Update of the RxHCC Model",0.318207998390311
"Section II Total Beneficiary Cost (TBC)","Section II Part C Cost Sharing Standards",0.316608724774335
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D.  Retiree Drug Subsidy Amounts",0.316532270435986
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Overview of CY 2019 Benefits and Bid Review",0.316471705369538
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section G.  MA Employer Group Waiver Plans",0.315985700235252
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Benefit Review",0.314853851773928
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Expanding the Part D OTC Program",0.314333915133046
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.31336487916798
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Maximum Out of Pocket (MOOP) Limits",0.312749066838171
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.311512875677332
"Section I Incomplete and Inaccurate Bid Submissions","Section G.  MA Employer Group Waiver Plans",0.310634921945152
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.309719730965832
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.307077734600667
"Section II Transparency   Timeliness with Prior Authorization Processes","Section E.  Clinical Trials",0.306223847933042
"Section II Cost Plan Competition Requirements","Section E.  Clinical Trials",0.305812750854997
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.305445119533249
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Maximum Out of Pocket (MOOP) Limits",0.303595013343731
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Innovations in Health Plan Design",0.302585965963793
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.30196452783189
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.301928875435407
"Section II Cost Plan Transition to MA under MACRA","Section II Part C Cost Sharing Standards",0.301787615523016
"Section I Annual Calendar","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.301236218847614
"Section II Total Beneficiary Cost (TBC)","Section B.  Calculation of Fee for Service Cost",0.30077856189561
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.2996530912041
"Section D.  Retiree Drug Subsidy Amounts","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.299449505303144
"Section II Health Related Supplemental Benefits","Section II Part C Cost Sharing Standards",0.299421930914313
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.298934181295643
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section E.  Clinical Trials",0.297415885175257
"Section II Employer Group Waiver Plans","Section I Plan Corrections",0.297133104639461
"Section D.  Retiree Drug Subsidy Amounts","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.296940104816421
"Section I Annual Calendar","Section II Overview of CY 2019 Benefits and Bid Review",0.296850077139401
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Cost Plan Transition to MA under MACRA",0.295552680674971
"Section I Annual Calendar","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.295384225419979
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.295162453695677
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Maximum Out of Pocket (MOOP) Limits",0.295069547713941
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Health Related Supplemental Benefits",0.293628971565022
"Section II Employer Group Waiver Plans","Section II Overview of CY 2019 Benefits and Bid Review",0.292543555790836
"Section III Tier Composition","Section III CY 2019 Formulary Submission Window",0.292493406248531
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Total Beneficiary Cost (TBC)",0.292383644378415
"Section III Benefit Review","Section II Medicare Advantage (MA) Uniformity Flexibility",0.291817711767641
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Maximum Out of Pocket (MOOP) Limits",0.290227376602582
"Section III Benefit Review","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.28988157301201
"Section III Benefit Review","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.289460616931451
"Section D.  Retiree Drug Subsidy Amounts","Section II Maximum Out of Pocket (MOOP) Limits",0.288291334140823
"Section II Overview of CY 2019 Benefits and Bid Review","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.287492073507444
"Section III Benefit Review","Section II Medicare Advantage (MA) Segmented Service Area Options",0.287387761073216
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Overview of CY 2019 Benefits and Bid Review",0.286891449772973
"Section II Part C Optional Supplemental Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.286653036317976
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Transparency   Timeliness with Prior Authorization Processes",0.286476814973291
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Cost Plan Competition Requirements",0.285928325798982
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.285778566340502
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Medicare Advantage (MA) Uniformity Flexibility",0.285705410373006
"Section II Tiered Cost Sharing of Medical Benefits","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.285073251915815
"Section I Enforcement Actions for Provider Directories","Section II Transparency   Timeliness with Prior Authorization Processes",0.284811977300788
"Section II Cost Plan Transition to MA under MACRA","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.284769100712788
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.284745935280671
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section E.  Clinical Trials",0.284095472120644
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Tiered Cost Sharing of Medical Benefits",0.283372693385386
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Total Beneficiary Cost (TBC)",0.283051827911363
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.282689115167728
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section IV   Medicare Medicaid Plans",0.282104277936212
"Section B.  FFS Growth Percentage","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.2819630641817
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section E.  Clinical Trials",0.281613690012291
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Total Beneficiary Cost (TBC)",0.281532491393625
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.28152686270189
"Section II Cost Plan Competition Requirements","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.281375816797501
"Section I Annual Calendar","Section II Cost Plan Competition Requirements",0.281297218767265
"Section II Overview of CY 2019 Benefits and Bid Review","Section IV   Medicare Medicaid Plans",0.28097627835006
"Section II Part C Cost Sharing Standards","Section IV   Medicare Medicaid Plans",0.280921467325618
"Section I Annual Calendar","Section II Part C Cost Sharing Standards",0.280714366412275
"Section A.  Update of the RxHCC Model","Section B.  Calculation of Fee for Service Cost",0.280680912853604
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.280541803843391
"Section I Incomplete and Inaccurate Bid Submissions","Section III CY 2019 Formulary Submission Window",0.279643674462003
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Medicare Advantage (MA) Uniformity Flexibility",0.279589425454561
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Total Beneficiary Cost (TBC)",0.279445057929098
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Maximum Out of Pocket (MOOP) Limits",0.279373766007407
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Overview of CY 2019 Benefits and Bid Review",0.278991255326959
"Section II Overview of CY 2019 Benefits and Bid Review","Section E.  Clinical Trials",0.277476054180533
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III CY 2019 Formulary Submission Window",0.276730167869748
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.275817505855531
"Section II Employer Group Waiver Plans","Section II Cost Plan Competition Requirements",0.274800500305611
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.27458230294393
"Section II Tiered Cost Sharing of Medical Benefits","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.274577014241038
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Part C Cost Sharing Standards",0.274477622022423
"Section II Cost Plan Transition to MA under MACRA","Section IV   Medicare Medicaid Plans",0.273346132874099
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Medicare Advantage (MA) Uniformity Flexibility",0.273268324121014
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section E.  Clinical Trials",0.272812730979426
"Section II Plans with Low Enrollment","Section II Cost Plan Transition to MA under MACRA",0.272708565152866
"Section II Cost Plan Competition Requirements","Section IV   Medicare Medicaid Plans",0.272084561812941
"Section I Annual Calendar","Section II Cost Plan Transition to MA under MACRA",0.271927824672575
"Section II Tiered Cost Sharing of Medical Benefits","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.270737085418285
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Maximum Out of Pocket (MOOP) Limits",0.270715919143405
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Tiered Cost Sharing of Medical Benefits",0.26980539002746
"Section II Total Beneficiary Cost (TBC)","Section I Incomplete and Inaccurate Bid Submissions",0.269239334045458
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Improving Access to Part D Vaccines",0.269104002151364
"Section II Outpatient Observation Services","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.268991106197506
"Section III Specialty Tiers","Section II Tiered Cost Sharing of Medical Benefits",0.268722785825293
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Tiered Cost Sharing of Medical Benefits",0.26858567535878
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section III Improving Access to Part D Vaccines",0.268204580336005
"Section D.  Retiree Drug Subsidy Amounts","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.267050105392081
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section O.  Quality Payment Program",0.267027210158384
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section E.  Clinical Trials",0.266716562198335
"Section D.  ESRD Rates","Section L.  Normalization Factors",0.265764568002883
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.26553084641492
"Section II Employer Group Waiver Plans","Section II Cost Plan Transition to MA under MACRA",0.265279054538645
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.265038695229005
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.264848739568996
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Expanding the Part D OTC Program",0.264697582061497
"Section II Overview of CY 2019 Benefits and Bid Review","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.264358172590519
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Incomplete and Inaccurate Bid Submissions",0.264087651656215
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Cost Plan Transition to MA under MACRA",0.264060393009748
"Section II Outpatient Observation Services","Section II Medicare Advantage (MA) Segmented Service Area Options",0.26400759676949
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section A.  Update of the RxHCC Model",0.263995465597779
"Section III Benefit Review","Section III Specialty Tiers",0.263415555922654
"Section II Overview of CY 2019 Benefits and Bid Review","Section G.  MA Employer Group Waiver Plans",0.262635856513893
"Section II Cost Plan Competition Requirements","Section II Plans with Low Enrollment",0.261687765647529
"Section II Outpatient Observation Services","Section II Cost Plan Competition Requirements",0.261602282463178
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.260177454235196
"Section II Outpatient Observation Services","Section II Overview of CY 2019 Benefits and Bid Review",0.258990845367379
"Section II Outpatient Observation Services","Section II Maximum Out of Pocket (MOOP) Limits",0.258709895460271
"Section III Benefit Review","Section II Total Beneficiary Cost (TBC)",0.258517960234704
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.25706155036869
"Section B.  FFS Growth Percentage","Section I.  ESRD Risk Adjustment Model for CY 2019",0.255882883218873
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.255776048613393
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Expanding the Part D OTC Program",0.255431200207053
"Section I Plan Corrections","Section III CY 2019 Formulary Submission Window",0.254356982050153
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Advantage (MA) Uniformity Flexibility",0.254224168783832
"Section II Cost Plan Transition to MA under MACRA","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.253518109304496
"Section II Cost Plan Competition Requirements","Section II Maximum Out of Pocket (MOOP) Limits",0.253301891548882
"Section III Improving Access to Part D Vaccines","Section II Total Beneficiary Cost (TBC)",0.25302145349537
"Section I Plan Corrections","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.252536431843297
"Section II Maximum Out of Pocket (MOOP) Limits","Section II Total Beneficiary Cost (TBC)",0.2523860860954
"Section I Innovations in Health Plan Design","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.252302437208825
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Part C Cost Sharing Standards",0.25214382186447
"Section III Benefit Review","Section II Part C Optional Supplemental Benefits",0.2515508427098
"Section II Outpatient Observation Services","Section III Improving Access to Part D Vaccines",0.2515116156297
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Part C Cost Sharing Standards",0.251422642257034
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section II Part C Cost Sharing Standards",0.251241042233337
"Section II Cost Plan Competition Requirements","Section III Improving Access to Part D Vaccines",0.250983465719768
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Improving Access to Part D Vaccines",0.250872412781816
"Section II Cost Plan Transition to MA under MACRA","Section II Tiered Cost Sharing of Medical Benefits",0.250561458770575
"Section D.  Retiree Drug Subsidy Amounts","Section III Improving Access to Part D Vaccines",0.250179450660244
"Section III Improving Drug Utilization Review Controls in Medicare Part D","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.249517797500876
"Section II Cost Plan Competition Requirements","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.248951292436221
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Part C Cost Sharing Standards",0.24804654157694
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section IV   Medicare Medicaid Plans",0.247838681923602
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.247420891032847
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Improving Access to Part D Vaccines",0.246784652058371
"Section D.  Retiree Drug Subsidy Amounts","Section II Tiered Cost Sharing of Medical Benefits",0.246737366096991
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Coordination of Benefits (COB) User Fee",0.246472588321202
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Medicare Advantage (MA) Uniformity Flexibility",0.246311405896261
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Innovations in Health Plan Design",0.246126973999356
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Part C Cost Sharing Standards",0.246016134781276
"Section III Specialty Tiers","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.245475558134247
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Health Related Supplemental Benefits",0.245094988471459
"Section II Cost Plan Competition Requirements","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.244998812685838
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section C.  Part D Risk Sharing",0.244607546208591
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section IV   Medicare Medicaid Plans",0.244464476725653
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section L.  Normalization Factors",0.244191487316554
"Section I Enforcement Actions for Provider Directories","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.243479837558753
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.243387365576057
"Section III Expanding the Part D OTC Program","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.242712727168737
"Section II Tiered Cost Sharing of Medical Benefits","Section II Total Beneficiary Cost (TBC)",0.242497859086638
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.242300305479554
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Improving Access to Part D Vaccines",0.242063018005747
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section C.  IME Phase Out",0.241713271209738
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Improving Access to Part D Vaccines",0.241330174095778
"Section I Annual Calendar","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.240873263944317
"Section A.  Update of the RxHCC Model","Section I Innovations in Health Plan Design",0.240420105490913
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.239922265080089
"Section II Outpatient Observation Services","Section E.  Clinical Trials",0.239220517887894
"Section II Part C Optional Supplemental Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.239170785026216
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.23910015208196
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.238801904297884
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section B.  Calculation of Fee for Service Cost",0.238728361641991
"Section C.  IME Phase Out","Section G.  MA Employer Group Waiver Plans",0.238676804041588
"Section II Maximum Out of Pocket (MOOP) Limits","Section E.  Clinical Trials",0.238669043960781
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section B.  Calculation of Fee for Service Cost",0.237802162720298
"Section II Part C Optional Supplemental Benefits","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.23743356358803
"Section II Total Beneficiary Cost (TBC)","Section G.  MA Employer Group Waiver Plans",0.237388972760129
"Section IV   Medicare Medicaid Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.236915582464039
"Section II Employer Group Waiver Plans","Section II Part C Optional Supplemental Benefits",0.236548412082446
"Section I Plan Corrections","Section IV   Medicare Medicaid Plans",0.236333918807226
"Section I Plan Corrections","Section I Validation Audits",0.236057428609465
"Section III Expanding the Part D OTC Program","Section III Improving Access to Part D Vaccines",0.2354399511622
"Section II Part C Optional Supplemental Benefits","Section II Total Beneficiary Cost (TBC)",0.234817848724577
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.234752606453209
"Section II Part C Optional Supplemental Benefits","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.234460259433922
"Section I Annual Calendar","Section III CY 2019 Formulary Submission Window",0.234250823072824
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section A.  Update of the RxHCC Model",0.23423019984364
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Overview of CY 2019 Benefits and Bid Review",0.234150503075426
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.233834946237594
"Section II Cost Plan Competition Requirements","Section II Transparency   Timeliness with Prior Authorization Processes",0.233695859131535
"Section III Improving Access to Part D Vaccines","Section E.  Clinical Trials",0.233522241407193
"Section I Annual Calendar","Section II Part C Optional Supplemental Benefits",0.233367573624078
"Section II Cost Plan Transition to MA under MACRA","Section III Improving Access to Part D Vaccines",0.232023689304054
"Section I Enforcement Actions for Provider Directories","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.231898263791619
"Section I Annual Calendar","Section II Medicare Advantage (MA) Uniformity Flexibility",0.231777539526914
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Maximum Out of Pocket (MOOP) Limits",0.231729399542655
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Cost Plan Transition to MA under MACRA",0.231182050411382
"Section III Tier Composition","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.230955415795003
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Plan Corrections",0.23093350966983
"Section III Benefit Review","Section II Health Related Supplemental Benefits",0.230626005796703
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Advantage (MA) Segmented Service Area Options",0.230428005254043
"Section II Cost Plan Transition to MA under MACRA","Section II Maximum Out of Pocket (MOOP) Limits",0.228936851392774
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section E.  Clinical Trials",0.228791695317237
"Section II Outpatient Observation Services","Section II Medicare Advantage (MA) Uniformity Flexibility",0.228458171600942
"Section III Benefit Review","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.228434081453446
"Section III Expanding the Part D OTC Program","Section III Tier Composition",0.228425306340159
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.228041607666156
"Section I Annual Calendar","Section I Plan Corrections",0.227869855956605
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Expanding the Part D OTC Program",0.227770560796513
"Section II Outpatient Observation Services","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.227217503671554
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Cost Plan Competition Requirements",0.226533166880255
"Section A.  Update of the RxHCC Model","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.22634433478492
"Section C.  IME Phase Out","Section B.  FFS Growth Percentage",0.226276637129136
"Section III Expanding the Part D OTC Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.226072483074413
"Section D.  ESRD Rates","Section G.  MA Employer Group Waiver Plans",0.225941180421805
"Section II Cost Plan Transition to MA under MACRA","Section E.  Clinical Trials",0.225817024914872
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Total Beneficiary Cost (TBC)",0.225790386134206
"Section II Plans with Low Enrollment","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.225774126046704
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.225552068008694
"Section II Part C Optional Supplemental Benefits","Section G.  MA Employer Group Waiver Plans",0.225211575382627
"Section I Annual Calendar","Section III Expanding the Part D OTC Program",0.225204824803453
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Expanding the Part D OTC Program",0.225177864158648
"Section I Annual Calendar","Section III Improving Access to Part D Vaccines",0.224277866284872
"Section II Employer Group Waiver Plans","Section IV   Medicare Medicaid Plans",0.222865275717135
"Section A.  Update of the RxHCC Model","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.222144812340169
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.221920938062084
"Section C.  IME Phase Out","Section D.  ESRD Rates",0.221677816002748
"Section I Annual Calendar","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.221555512915727
"Section II Part C Optional Supplemental Benefits","Section II Cost Plan Transition to MA under MACRA",0.221539510248684
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.221079779430995
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.220981859609684
"Section II Part C Cost Sharing Standards","Section I Incomplete and Inaccurate Bid Submissions",0.220958086359838
"Section I Incomplete and Inaccurate Bid Submissions","Section IV   Medicare Medicaid Plans",0.2205113535913
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section IV   Medicare Medicaid Plans",0.220089610689391
"Section II Cost Plan Competition Requirements","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.220028278889035
"Section I Annual Calendar","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.219956013195601
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Total Beneficiary Cost (TBC)",0.219820381094506
"Section III Coordination of Benefits (COB) User Fee","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.219793133918992
"Section B.  Calculation of Fee for Service Cost","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.219608146927101
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Tiered Cost Sharing of Medical Benefits",0.219553363808464
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Plans with Low Enrollment",0.219545195083105
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.219350712644468
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section G.  MA Employer Group Waiver Plans",0.218808346233968
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.218504223588806
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Tier Composition",0.21830925767331
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section A.  Update of the RxHCC Model",0.217995302230229
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Cost Plan Competition Requirements",0.217586767784735
"Section II Cost Plan Transition to MA under MACRA","Section I Incomplete and Inaccurate Bid Submissions",0.217524582400405
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Tier Composition",0.21716298026025
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Maximum Out of Pocket (MOOP) Limits",0.216786860526889
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.216183817097966
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Cost Plan Competition Requirements",0.215940463671241
"Section D.  Retiree Drug Subsidy Amounts","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.215735239588986
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.215704813542641
"Section II Cost Plan Transition to MA under MACRA","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.215436309688058
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III Expanding the Part D OTC Program",0.215202644936465
"Section II Employer Group Waiver Plans","Section II Medicare Advantage (MA) Uniformity Flexibility",0.214758606471155
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section IV   Medicare Medicaid Plans",0.214722856083542
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section E.  Clinical Trials",0.214488238639733
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.214396115520379
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Part C Cost Sharing Standards",0.214365350493941
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Overview of CY 2019 Benefits and Bid Review",0.214012912501926
"Section II Part C Optional Supplemental Benefits","Section IV   Medicare Medicaid Plans",0.213990167583515
"Section III Improving Access to Part D Vaccines","Section III CY 2019 Formulary Submission Window",0.213651584081942
"Section III CY 2019 Formulary Submission Window","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.213508327961473
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Total Beneficiary Cost (TBC)",0.213458674491185
"Section I Innovations in Health Plan Design","Section II Total Beneficiary Cost (TBC)",0.213458172863754
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section L.  Normalization Factors",0.213210092232405
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.213208372639755
"Section III Specialty Tiers","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.212700789989576
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Transparency   Timeliness with Prior Authorization Processes",0.212346326311995
"Section III Expanding the Part D OTC Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.212137876285943
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.211856704717928
"Section II Total Beneficiary Cost (TBC)","Section IV   Medicare Medicaid Plans",0.211733481779004
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section D.  ESRD Rates",0.211650633884436
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.211587984908668
"Section II Part C Cost Sharing Standards","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.211248317905863
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section IV   Medicare Medicaid Plans",0.211209775156029
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Cost Plan Transition to MA under MACRA",0.210397127149918
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section E.  Clinical Trials",0.210125958143778
"Section II Tiered Cost Sharing of Medical Benefits","Section IV   Medicare Medicaid Plans",0.210109101205973
"Section D.  Retiree Drug Subsidy Amounts","Section II Overview of CY 2019 Benefits and Bid Review",0.209856926347721
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.209443866102271
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.209215304820283
"Section II Tiered Cost Sharing of Medical Benefits","Section II Health Related Supplemental Benefits",0.208348016487662
"Section II Part C Optional Supplemental Benefits","Section III Low Enrollment Plans (Stand alone PDPs only)",0.208346790167712
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III CY 2019 Formulary Submission Window",0.207722310679598
"Section A.  Update of the RxHCC Model","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.207538795299
"Section II Part C Optional Supplemental Benefits","Section II Part C Cost Sharing Standards",0.207501084670382
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Tier Composition",0.207495562910001
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.207395844944979
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.207283654896009
"Section II Cost Plan Competition Requirements","Section II Total Beneficiary Cost (TBC)",0.207015828722671
"Section II Plans with Low Enrollment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.20696094669059
"Section I Annual Calendar","Section II Total Beneficiary Cost (TBC)",0.206819501151336
"Section III Expanding the Part D OTC Program","Section II Part C Cost Sharing Standards",0.206772762046596
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Transparency   Timeliness with Prior Authorization Processes",0.206662429110642
"Section L.  Normalization Factors","Section G.  MA Employer Group Waiver Plans",0.206609213664874
"Section III Specialty Tiers","Section III CY 2019 Formulary Submission Window",0.206549554034556
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Outpatient Observation Services",0.206363321487491
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III CY 2019 Formulary Submission Window",0.206325359021425
"Section D.  Retiree Drug Subsidy Amounts","Section IV   Medicare Medicaid Plans",0.206222171876521
"Section II Overview of CY 2019 Benefits and Bid Review","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.206003817386595
"Section III Improving Access to Part D Vaccines","Section IV   Medicare Medicaid Plans",0.205880579123683
"Section II Total Beneficiary Cost (TBC)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.205665947682991
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.205540916167741
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Total Beneficiary Cost (TBC)",0.20474086044402
"Section A.  MA Growth Percentage","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.204415493377697
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section E.  Clinical Trials",0.204366313971251
"Section A.  MA Growth Percentage","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.204166332717188
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Outpatient Observation Services",0.204124145231931
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.203763799499562
"Section I Plan Corrections","Section G.  MA Employer Group Waiver Plans",0.203434339473147
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Advantage (MA) Uniformity Flexibility",0.203147875697479
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.203022140279132
"Section III Tier Composition","Section II Part C Cost Sharing Standards",0.20270919501235
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Annual Calendar",0.202677986819794
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.202014152747307
"Section L.  Normalization Factors","Section B.  Calculation of Fee for Service Cost",0.201834214602691
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section IV   Medicare Medicaid Plans",0.201779556863481
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Cost Plan Competition Requirements",0.201391805240127
"Section O.  Quality Payment Program","Section G.  MA Employer Group Waiver Plans",0.201195281770844
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I.  ESRD Risk Adjustment Model for CY 2019",0.201009628003565
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section L.  Normalization Factors",0.200984316160876
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Innovations in Health Plan Design",0.200942615224685
"Section C.  Part D Risk Sharing","Section L.  Normalization Factors",0.200869093976466
"Section II Health Related Supplemental Benefits","Section IV   Medicare Medicaid Plans",0.200573283987039
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Plans with Low Enrollment",0.20055373150866
"Section II Employer Group Waiver Plans","Section II Part C Cost Sharing Standards",0.200395617181045
"Section I Annual Calendar","Section II Tiered Cost Sharing of Medical Benefits",0.200374753095903
"Section I Plan Corrections","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.200052346990052
"Section I Annual Calendar","Section II Transparency   Timeliness with Prior Authorization Processes",0.199750173720231
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Cost Plan Transition to MA under MACRA",0.199681237069032
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.199588053115666
"Section II Part C Cost Sharing Standards","Section B.  Calculation of Fee for Service Cost",0.199558643470471
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Transparency   Timeliness with Prior Authorization Processes",0.199262143354846
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section IV   Medicare Medicaid Plans",0.199256799313959
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Medicare Advantage (MA) Segmented Service Area Options",0.199178641293541
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.198703347218373
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.198618007689446
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Medicare Advantage (MA) Segmented Service Area Options",0.198599217226406
"Section II Part C Optional Supplemental Benefits","Section II Plans with Low Enrollment",0.198239087696302
"Section III Expanding the Part D OTC Program","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.197516184111968
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section B.  Calculation of Fee for Service Cost",0.197022258120027
"Section III Benefit Review","Section IV   Medicare Medicaid Plans",0.196925463579681
"Section I Annual Calendar","Section D.  Retiree Drug Subsidy Amounts",0.196695768039465
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.196640021117466
"Section III Coordination of Benefits (COB) User Fee","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.196593722686098
"Section II Cost Plan Transition to MA under MACRA","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.195991528851239
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Maximum Out of Pocket (MOOP) Limits",0.19581475538747
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.19563565662362
"Section II Part C Optional Supplemental Benefits","Section I Plan Corrections",0.195489567612675
"Section III Coordination of Benefits (COB) User Fee","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.195235382189872
"Section I Annual Calendar","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.195026427871586
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)",0.194986671288573
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section C.  Part D Risk Sharing",0.194394818965386
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Health Related Supplemental Benefits",0.194355536162844
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Incomplete and Inaccurate Bid Submissions",0.194238883029114
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.194015785384513
"Section I Annual Calendar","Section II Health Related Supplemental Benefits",0.193685833864782
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Plans with Low Enrollment",0.193488651473137
"Section I Incomplete and Inaccurate Bid Submissions","Section I Validation Audits",0.193467229358338
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.19345763577579
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section IV   Medicare Medicaid Plans",0.1933012548243
"Section I Annual Calendar","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.193134406177407
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.192877119913624
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Total Beneficiary Cost (TBC)",0.192815476491454
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Cost Plan Transition to MA under MACRA",0.192800445180522
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Annual Calendar",0.192442280364736
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section IV   Medicare Medicaid Plans",0.192004347975567
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Health Related Supplemental Benefits",0.191025115815421
"Section III Expanding the Part D OTC Program","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.190831448174789
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Tiered Cost Sharing of Medical Benefits",0.190718516692791
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.190512325447655
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section A.  Update of the RxHCC Model",0.190159428330441
"Section I Annual Calendar","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.190007812136034
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Total Beneficiary Cost (TBC)",0.189748992002164
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Incomplete and Inaccurate Bid Submissions",0.189602273173635
"Section I Annual Calendar","Section G.  MA Employer Group Waiver Plans",0.189521307816942
"Section III Benefit Review","Section D.  Retiree Drug Subsidy Amounts",0.189466186686268
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.189375488304243
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.189048833481874
"Section A.  Update of the RxHCC Model","Section II Total Beneficiary Cost (TBC)",0.189005491563645
"Section D.  Retiree Drug Subsidy Amounts","Section E.  Clinical Trials",0.188887910451068
"Section III Specialty Tiers","Section C.  Part D Risk Sharing",0.188821390751655
"Section III Expanding the Part D OTC Program","Section II Health Related Supplemental Benefits",0.188759438207871
"Section II Employer Group Waiver Plans","Section III Benefit Review",0.188656123687852
"Section III Benefit Review","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.188597735116456
"Section II Cost Plan Transition to MA under MACRA","Section II Total Beneficiary Cost (TBC)",0.188313619936134
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section A.  Update of the RxHCC Model",0.187681085983392
"Section II Cost Plan Competition Requirements","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.187649832916167
"Section III Benefit Review","Section II Outpatient Observation Services",0.187141299261314
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Overview of CY 2019 Benefits and Bid Review",0.186612875813077
"Section I Plan Corrections","Section II Total Beneficiary Cost (TBC)",0.186364257993835
"Section II Overview of CY 2019 Benefits and Bid Review","Section B.  Calculation of Fee for Service Cost",0.186281838380806
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A.  Update of the RxHCC Model",0.185878422445207
"Section D.  ESRD Rates","Section II Total Beneficiary Cost (TBC)",0.185549842354813
"Section II Transparency   Timeliness with Prior Authorization Processes","Section IV   Medicare Medicaid Plans",0.185465125250959
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Medicare Advantage (MA) Uniformity Flexibility",0.185297478373707
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.185289672290994
"Section O.  Quality Payment Program","Section B.  Calculation of Fee for Service Cost",0.185193743416991
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.185041182728599
"Section III Specialty Tiers","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.184794793174539
"Section II Health Related Supplemental Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.184775653962821
"Section A.  MA Growth Percentage","Section II Total Beneficiary Cost (TBC)",0.184676191377155
"Section D.  Retiree Drug Subsidy Amounts","Section II Total Beneficiary Cost (TBC)",0.183981149986389
"Section II Total Beneficiary Cost (TBC)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.183935860555646
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.183933905212651
"Section II Part C Cost Sharing Standards","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.183864439058789
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.183860156839746
"Section I Innovations in Health Plan Design","Section O.  Quality Payment Program",0.183782603446088
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section I.  ESRD Risk Adjustment Model for CY 2019",0.183455928555419
"Section IV   Medicare Medicaid Plans","Section B.  Calculation of Fee for Service Cost",0.183292663327568
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section B.  Calculation of Fee for Service Cost",0.183216461028191
"Section III Benefit Review","Section II Cost Plan Competition Requirements",0.183192405144084
"Section II Part C Optional Supplemental Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.182996786385052
"Section II Employer Group Waiver Plans","Section G.  MA Employer Group Waiver Plans",0.182683817838292
"Section III Coordination of Benefits (COB) User Fee","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.181799103187225
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.181700542393113
"Section II Cost Plan Competition Requirements","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.18127963739468
"Section C.  IME Phase Out","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.181238247339352
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.181111362358677
"Section B.  FFS Growth Percentage","Section L.  Normalization Factors",0.181100683187259
"Section B.  FFS Growth Percentage","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.180927713813976
"Section III Improving Access to Part D Vaccines","Section I Incomplete and Inaccurate Bid Submissions",0.180584172323409
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Expanding the Part D OTC Program",0.180355272015757
"Section II Cost Plan Competition Requirements","Section III Low Enrollment Plans (Stand alone PDPs only)",0.180060921539665
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.179904269135333
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I.  ESRD Risk Adjustment Model for CY 2019",0.179493537614576
"Section II Cost Plan Competition Requirements","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.179455603467554
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Incomplete and Inaccurate Bid Submissions",0.17929922374544
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Transparency   Timeliness with Prior Authorization Processes",0.179150351547373
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section IV   Medicare Medicaid Plans",0.178940373016772
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section IV   Medicare Medicaid Plans",0.178848617687408
"Section II Tiered Cost Sharing of Medical Benefits","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.17884567120675
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Medicare Advantage (MA) Uniformity Flexibility",0.178433022399191
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.178038983330066
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.177898949114956
"Section III Specialty Tiers","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.177865634357283
"Section O.  Quality Payment Program","Section L.  Normalization Factors",0.177697224416042
"Section III Coordination of Benefits (COB) User Fee","Section III Expanding the Part D OTC Program",0.177678688809818
"Section D.  Retiree Drug Subsidy Amounts","Section II Medicare Advantage (MA) Uniformity Flexibility",0.177508680653883
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section B.  Calculation of Fee for Service Cost",0.177195511115476
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Total Beneficiary Cost (TBC)",0.177163992039009
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section I Incomplete and Inaccurate Bid Submissions",0.176821780742288
"Section A.  Update of the RxHCC Model","Section D.  ESRD Rates",0.176776960785111
"Section I Annual Calendar","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.17618590654313
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.175699547334246
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Incomplete and Inaccurate Bid Submissions",0.175393145874247
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Low Enrollment Plans (Stand alone PDPs only)",0.17532546080165
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section D.  Retiree Drug Subsidy Amounts",0.1752668150593
"Section III Benefit Review","Section II Cost Plan Transition to MA under MACRA",0.175015617795393
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section G.  MA Employer Group Waiver Plans",0.174770899617609
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section D.  ESRD Rates",0.174225989897319
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Low Enrollment Plans (Stand alone PDPs only)",0.174142823627438
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.174141349205323
"Section II Outpatient Observation Services","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.174098829136264
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Plans with Low Enrollment",0.173758843680648
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.173715059265161
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Health Related Supplemental Benefits",0.17361699903101
"Section II Outpatient Observation Services","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.173288895101375
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Low Enrollment Plans (Stand alone PDPs only)",0.173142596774724
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section B.  Calculation of Fee for Service Cost",0.173098362439273
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section O.  Quality Payment Program",0.173036760775236
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section III CY 2019 Formulary Submission Window",0.17301498302029
"Section II Employer Group Waiver Plans","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.172532822315488
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Tiered Cost Sharing of Medical Benefits",0.172523521411617
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.172520549814124
"Section III Benefit Review","Section I Annual Calendar",0.17228999027632
"Section III Coordination of Benefits (COB) User Fee","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.172158711298749
"Section A.  Update of the RxHCC Model","Section II Health Related Supplemental Benefits",0.172054804301007
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Plans with Low Enrollment",0.171917019892426
"Section B.  FFS Growth Percentage","Section II Total Beneficiary Cost (TBC)",0.171743628802302
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Plans with Low Enrollment",0.17171250548799
"Section II Employer Group Waiver Plans","Section I Annual Calendar",0.171587429871974
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Overview of CY 2019 Benefits and Bid Review",0.171574167261623
"Section II Maximum Out of Pocket (MOOP) Limits","Section IV   Medicare Medicaid Plans",0.171551854784985
"Section III Specialty Tiers","Section III Expanding the Part D OTC Program",0.171544979999341
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section D.  ESRD Rates",0.171186960899877
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.171117052778599
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.170824544117359
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Cost Plan Transition to MA under MACRA",0.170558729415614
"Section C.  IME Phase Out","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.170533822769176
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Expanding the Part D OTC Program",0.170503525556482
"Section II Health Related Supplemental Benefits","Section II Total Beneficiary Cost (TBC)",0.170479427437652
"Section II Part C Optional Supplemental Benefits","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.170441708143521
"Section B.  FFS Growth Percentage","Section G.  MA Employer Group Waiver Plans",0.170394953891751
"Section II Outpatient Observation Services","Section II Health Related Supplemental Benefits",0.170293764780637
"Section D.  ESRD Rates","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.170277922787023
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Innovations in Health Plan Design",0.169935812459017
"Section II Employer Group Waiver Plans","Section II Meaningful Difference (Substantially Duplicative Plan Offerings)",0.169851219212005
"Section II Employer Group Waiver Plans","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.169799110648923
"Section III Expanding the Part D OTC Program","Section IV   Medicare Medicaid Plans",0.169760201682797
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.169625011212824
"Section II Cost Plan Competition Requirements","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.16946937681145
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Improving Access to Part D Vaccines",0.169383580377762
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.169257789156242
"Section II Employer Group Waiver Plans","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.169224074107312
"Section III Expanding the Part D OTC Program","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.168797603341889
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.168582333717554
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Tiered Cost Sharing of Medical Benefits",0.168485716190944
"Section IV   Medicare Medicaid Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.168141703874353
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section E.  Clinical Trials",0.168067690871575
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Cost Plan Transition to MA under MACRA",0.168013405764423
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.167945445110566
"Section A.  Update of the RxHCC Model","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.167933223834113
"Section II Total Beneficiary Cost (TBC)","Section III CY 2019 Formulary Submission Window",0.167846222016957
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section IV   Medicare Medicaid Plans",0.167845534447506
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section B.  Calculation of Fee for Service Cost",0.166635113384984
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.166627446365696
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B.  Calculation of Fee for Service Cost",0.166597238088353
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section II Maximum Out of Pocket (MOOP) Limits",0.166565934305542
"Section II Maximum Out of Pocket (MOOP) Limits","Section B.  Calculation of Fee for Service Cost",0.166447894079837
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Part C Optional Supplemental Benefits",0.166277664641681
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Innovations in Health Plan Design",0.166173250745494
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section E.  Clinical Trials",0.165860812116717
"Section II Employer Group Waiver Plans","Section II Total Beneficiary Cost (TBC)",0.165852788057313
"Section II Outpatient Observation Services","Section D.  Retiree Drug Subsidy Amounts",0.165847016440983
"Section G.  MA Employer Group Waiver Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.165786569412176
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section E.  Clinical Trials",0.165725418728089
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.165721055579457
"Section II Total Beneficiary Cost (TBC)","Section E.  Clinical Trials",0.165704018463482
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.16563723161901
"Section III Benefit Review","Section III Expanding the Part D OTC Program",0.165512780532141
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.165426085865574
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.165205593804581
"Section II Employer Group Waiver Plans","Section II Medicare Advantage (MA) Segmented Service Area Options",0.165009663911228
"Section III Benefit Review","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.164943631299413
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.164644116978263
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section G.  MA Employer Group Waiver Plans",0.164620713505865
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Overview of CY 2019 Benefits and Bid Review",0.164570028434301
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.164433037755102
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section B.  Calculation of Fee for Service Cost",0.164216744986023
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.164208556625497
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Low Enrollment Plans (Stand alone PDPs only)",0.164172085948022
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.16413763581944
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.163918590012361
"Section II Cost Plan Competition Requirements","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.163823733340961
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.163759206145855
"Section I Annual Calendar","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.163680631682629
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III CY 2019 Formulary Submission Window",0.163500690183115
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.163492598918368
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section C.  IME Phase Out",0.163110326802033
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.163101670387323
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.162914645168851
"Section I Innovations in Health Plan Design","Section L.  Normalization Factors",0.162849812917199
"Section II Cost Plan Transition to MA under MACRA","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.162656735872449
"Section I Annual Calendar","Section II Medicare Advantage (MA) Segmented Service Area Options",0.162286802239536
"Section II Cost Plan Competition Requirements","Section B.  Calculation of Fee for Service Cost",0.162229123603835
"Section II Outpatient Observation Services","Section IV   Medicare Medicaid Plans",0.162178530318433
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section C.  Part D Risk Sharing",0.162089434687417
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section O.  Quality Payment Program",0.161870408552022
"Section II Cost Plan Competition Requirements","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.16182078031209
"Section A.  Update of the RxHCC Model","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.161800591732743
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Overview of CY 2019 Benefits and Bid Review",0.161543240994993
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section E.  Clinical Trials",0.161526805409726
"Section II Overview of CY 2019 Benefits and Bid Review","Section O.  Quality Payment Program",0.161363369381057
"Section II Plans with Low Enrollment","Section G.  MA Employer Group Waiver Plans",0.161123978115781
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section B.  Calculation of Fee for Service Cost",0.160802980100781
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I Incomplete and Inaccurate Bid Submissions",0.160761282624722
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.160704164114301
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.16053228696206
"Section II Health Related Supplemental Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.160298532243108
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section B.  Calculation of Fee for Service Cost",0.160149608107291
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Total Beneficiary Cost (TBC)",0.160114817670614
"Section III Benefit Review","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.159884412029704
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section IV   Medicare Medicaid Plans",0.159585713564708
"Section III Coordination of Benefits (COB) User Fee","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.159534029246462
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.159477411359368
"Section II Employer Group Waiver Plans","Section H.  CMS HCC Risk Adjustment Model for CY 2019",0.159348202154215
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Cost Plan Transition to MA under MACRA",0.159248686203758
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Plans with Low Enrollment",0.158955666506705
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Meaningful Difference (Substantially Duplicative Plan Offerings)",0.158867681039848
"Section II Health Related Supplemental Benefits","Section E.  Clinical Trials",0.158753723815792
"Section III Coordination of Benefits (COB) User Fee","Section III Improving Access to Part D Vaccines",0.158675613784628
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I.  ESRD Risk Adjustment Model for CY 2019",0.158650002041677
"Section III Expanding the Part D OTC Program","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.158627111589339
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section I.  ESRD Risk Adjustment Model for CY 2019",0.158586890342284
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.158083117229385
"Section II Part C Optional Supplemental Benefits","Section II Cost Plan Competition Requirements",0.158067813713131
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Coordination of Benefits (COB) User Fee",0.157985471244011
"Section E.  Clinical Trials","Section IV   Medicare Medicaid Plans",0.157817481495802
"Section II Part C Optional Supplemental Benefits","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.157652659516765
"Section O.  Quality Payment Program","Section II Total Beneficiary Cost (TBC)",0.157652133309095
"Section III Specialty Tiers","Section II Total Beneficiary Cost (TBC)",0.157638990047033
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Total Beneficiary Cost (TBC)",0.157482149315875
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Expanding the Part D OTC Program",0.157473940204392
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.157333535764787
"Section I Innovations in Health Plan Design","Section E.  Clinical Trials",0.157260140891866
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.157102456885832
"Section I Annual Calendar","Section III Coordination of Benefits (COB) User Fee",0.157092384680762
"Section II Tiered Cost Sharing of Medical Benefits","Section III Expanding the Part D OTC Program",0.157013734395772
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section B.  Encounter Data as a Diagnosis Source for 2019",0.156830002706829
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Overview of CY 2019 Benefits and Bid Review",0.156809226014508
"Section C.  IME Phase Out","Section II Medicare Advantage (MA) Uniformity Flexibility",0.156769952211833
"Section III Tier Composition","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.156512032358103
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section O.  Quality Payment Program",0.156499313705064
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Tiered Cost Sharing of Medical Benefits",0.156497685042715
"Section II Part C Cost Sharing Standards","Section G.  MA Employer Group Waiver Plans",0.156366006693559
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Outpatient Observation Services",0.156362987032998
"Section II Total Beneficiary Cost (TBC)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.156162430290784
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.156052160805043
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Expanding the Part D OTC Program",0.155894663037101
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section G.  MA Employer Group Waiver Plans",0.155884704406414
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section III CY 2019 Formulary Submission Window",0.155697170084148
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Tier Composition",0.155514824158556
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B.  Calculation of Fee for Service Cost",0.155467465046914
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Coordination of Benefits (COB) User Fee",0.155460731723621
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Coordination of Benefits (COB) User Fee",0.155202693728993
"Section II Employer Group Waiver Plans","Section II Plans with Low Enrollment",0.155087172016385
"Section A.  Update of the RxHCC Model","Section III Improving Access to Part D Vaccines",0.155070814833971
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Medicare Advantage (MA) Uniformity Flexibility",0.154936345100212
"Section I Annual Calendar","Section III Tier Composition",0.154932648944973
"Section III Tier Composition","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.15484614608924
"Section I Innovations in Health Plan Design","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.154829347130755
"Section III Benefit Review","Section E.  Clinical Trials",0.154770927412108
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Expanding the Part D OTC Program",0.154754634865575
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Cost Plan Competition Requirements",0.154711969582649
"Section II Part C Optional Supplemental Benefits","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.154589700007996
"Section III Coordination of Benefits (COB) User Fee","Section IV   Medicare Medicaid Plans",0.154497852683948
"Section II Maximum Out of Pocket (MOOP) Limits","Section G.  MA Employer Group Waiver Plans",0.153950946506046
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Overview of CY 2019 Benefits and Bid Review",0.153834900137643
"Section II Overview of CY 2019 Benefits and Bid Review","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.15380795785925
"Section III Expanding the Part D OTC Program","Section I Innovations in Health Plan Design",0.153592515870485
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Expanding the Part D OTC Program",0.153348089855037
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Specialty Tiers",0.153329651494723
"Section D.  ESRD Rates","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.153248546061109
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.153049119596024
"Section III Improving Access to Part D Vaccines","Section B.  Calculation of Fee for Service Cost",0.152979042200408
"Section II Employer Group Waiver Plans","Section II Tiered Cost Sharing of Medical Benefits",0.152978736000857
"Section I Annual Calendar","Section II Maximum Out of Pocket (MOOP) Limits",0.152785981856297
"Section II Employer Group Waiver Plans","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.152778796910616
"Section II Total Beneficiary Cost (TBC)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.152573406827704
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.152489010304798
"Section II Cost Plan Competition Requirements","Section II Health Related Supplemental Benefits",0.152433535733311
"Section II Outpatient Observation Services","Section II Transparency   Timeliness with Prior Authorization Processes",0.152432440574107
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.152343132985296
"Section I Annual Calendar","Section II Plans with Low Enrollment",0.152138941468746
"Section III Expanding the Part D OTC Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.1518368073542
"Section III Benefit Review","Section II Meaningful Difference (Substantially Duplicative Plan Offerings)",0.151372784685434
"Section A.  MA Growth Percentage","Section B.  Calculation of Fee for Service Cost",0.151366094323464
"Section III Improving Access to Part D Vaccines","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.151254474529963
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.150991137277621
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section B.  Calculation of Fee for Service Cost",0.150925969561942
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.150678066048621
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section B.  FFS Growth Percentage",0.150633996988761
"Section II Cost Plan Transition to MA under MACRA","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.15024010069553
"Section I Annual Calendar","Section E.  Clinical Trials",0.150051081372543
"Section II Part C Optional Supplemental Benefits","Section III Expanding the Part D OTC Program",0.14998295745038
"Section I Innovations in Health Plan Design","Section B.  Calculation of Fee for Service Cost",0.149891185999337
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.149817012209449
"Section III Expanding the Part D OTC Program","Section II Total Beneficiary Cost (TBC)",0.149675307440624
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section A.  Update of the RxHCC Model",0.149390676317275
"Section C.  IME Phase Out","Section II Total Beneficiary Cost (TBC)",0.149331300634973
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section M.  Medical Loss Ratio Credibility Adjustment",0.149211229821997
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section D.  ESRD Rates",0.149192935232942
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.148891856957096
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.148817456643694
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D.  ESRD Rates",0.14862188364948
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Plan Corrections",0.148361506419164
"Section I Annual Calendar","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.14835388774012
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.148035865086666
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section I Incomplete and Inaccurate Bid Submissions",0.148018376979687
"Section III Tier Composition","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.147899917339609
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Validation Audits",0.147863853779794
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B.  Calculation of Fee for Service Cost",0.147783389040364
"Section III Coordination of Benefits (COB) User Fee","Section III CY 2019 Formulary Submission Window",0.147531670190673
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Incomplete and Inaccurate Bid Submissions",0.147511572132267
"Section II Employer Group Waiver Plans","Section II Maximum Out of Pocket (MOOP) Limits",0.147403175150016
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Plans with Low Enrollment",0.147322769201874
"Section C.  Part D Risk Sharing","Section II Total Beneficiary Cost (TBC)",0.147128937359756
"Section A.  Update of the RxHCC Model","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.147125617039599
"Section II Employer Group Waiver Plans","Section II Health Related Supplemental Benefits",0.147095470701356
"Section B.  FFS Growth Percentage","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.14704052393104
"Section A.  Update of the RxHCC Model","Section C.  Part D Risk Sharing",0.146993704055736
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I.  ESRD Risk Adjustment Model for CY 2019",0.146891222897088
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Incomplete and Inaccurate Bid Submissions",0.146870288132869
"Section II Maximum Out of Pocket (MOOP) Limits","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.146845908319133
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Medicare Advantage (MA) Uniformity Flexibility",0.146605909324597
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.146585253023609
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.146434382167333
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section B.  Calculation of Fee for Service Cost",0.146411765267451
"Section III Tier Composition","Section IV   Medicare Medicaid Plans",0.146410844292144
"Section II Cost Plan Competition Requirements","Section III Expanding the Part D OTC Program",0.146375717540947
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section II Total Beneficiary Cost (TBC)",0.146316783245395
"Section II Plans with Low Enrollment","Section E.  Clinical Trials",0.146144192159411
"Section II Employer Group Waiver Plans","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.145896036510803
"Section C.  IME Phase Out","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.145838446233238
"Section II Employer Group Waiver Plans","Section I Validation Audits",0.145733049144838
"Section III Specialty Tiers","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.145707159095983
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section III CY 2019 Formulary Submission Window",0.14569352782656
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section III CY 2019 Formulary Submission Window",0.145683591786487
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section G.  MA Employer Group Waiver Plans",0.145615132306794
"Section III Specialty Tiers","Section III Coordination of Benefits (COB) User Fee",0.145547367944222
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.145484517158849
"Section A.  Update of the RxHCC Model","Section IV   Medicare Medicaid Plans",0.145418736086784
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Cost Plan Transition to MA under MACRA",0.145385784171174
"Section I Enforcement Actions for Provider Directories","Section II Tiered Cost Sharing of Medical Benefits",0.145347812168712
"Section II Plans with Low Enrollment","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.145279302099021
"Section O.  Quality Payment Program","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.14522353571483
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Cost Plan Transition to MA under MACRA",0.145207067712505
"Section II Part C Optional Supplemental Benefits","Section III Tier Composition",0.145100765653013
"Section II Cost Plan Competition Requirements","Section I Incomplete and Inaccurate Bid Submissions",0.145082987952111
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section IV   Medicare Medicaid Plans",0.145024332875668
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.145006098459252
"Section II Employer Group Waiver Plans","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.144951357863786
"Section II Maximum Out of Pocket (MOOP) Limits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.144828986747723
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section A.  Update of the RxHCC Model",0.144582746926056
"Section I Enforcement Actions for Provider Directories","Section II Overview of CY 2019 Benefits and Bid Review",0.144425428402562
"Section I Annual Calendar","Section A.  Update of the RxHCC Model",0.144407560121515
"Section C.  IME Phase Out","Section II Part C Cost Sharing Standards",0.144387658420656
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.144277079882575
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Plans with Low Enrollment",0.144108936640411
"Section II Cost Plan Transition to MA under MACRA","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.143964052242002
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section O.  Quality Payment Program",0.143788452093464
"Section A.  Update of the RxHCC Model","Section G.  MA Employer Group Waiver Plans",0.14368616030191
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Part C Cost Sharing Standards",0.143661376445264
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I.  ESRD Risk Adjustment Model for CY 2019",0.143637676679348
"Section II Part C Optional Supplemental Benefits","Section A.  Update of the RxHCC Model",0.143621510738034
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.143512813077021
"Section II Employer Group Waiver Plans","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.143471838479397
"Section I Annual Calendar","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.14329951688593
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Total Beneficiary Cost (TBC)",0.143273096189736
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.143056099992123
"Section I Annual Calendar","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.143036313105177
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Part C Optional Supplemental Benefits",0.142920454275172
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Plans with Low Enrollment",0.14270857592093
"Section M.  Medical Loss Ratio Credibility Adjustment","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.142705427995862
"Section III Specialty Tiers","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.142535858503201
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.142264261282513
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section I Incomplete and Inaccurate Bid Submissions",0.142239455574112
"Section B.  FFS Growth Percentage","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.14206930350496
"Section II Outpatient Observation Services","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.142056580378424
"Section I Innovations in Health Plan Design","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.14198277448435
"Section III Coordination of Benefits (COB) User Fee","Section III Tier Composition",0.141813338231596
"Section II Health Related Supplemental Benefits","Section II Maximum Out of Pocket (MOOP) Limits",0.141758652674496
"Section I Annual Calendar","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.141633771895642
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.1416203204843
"Section II Employer Group Waiver Plans","Section C.  IME Phase Out",0.14159136794715
"Section III CY 2019 Formulary Submission Window","Section I Validation Audits",0.141509630021205
"Section II Outpatient Observation Services","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.141452853132822
"Section III Tier Composition","Section II Total Beneficiary Cost (TBC)",0.141428661931878
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section IV   Medicare Medicaid Plans",0.141266739133294
"Section A.  Update of the RxHCC Model","Section II Part C Cost Sharing Standards",0.141153857949318
"Section II Plans with Low Enrollment","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.141124903947756
"Section II Total Beneficiary Cost (TBC)","Section L.  Normalization Factors",0.141077747835114
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.141033947303908
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section E.  Clinical Trials",0.140950840137686
"Section I Annual Calendar","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.140944164711212
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.140900303173062
"Section C.  IME Phase Out","Section O.  Quality Payment Program",0.140782035133427
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.140706574887032
"Section II Cost Plan Transition to MA under MACRA","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.140611019591813
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.140533787539269
"Section C.  IME Phase Out","Section II Maximum Out of Pocket (MOOP) Limits",0.140465883745988
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.14037783103335
"Section III Expanding the Part D OTC Program","Section I Validation Audits",0.140102566702533
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section IV   Medicare Medicaid Plans",0.139995176087308
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Part C Cost Sharing Standards",0.139991547253448
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Incomplete and Inaccurate Bid Submissions",0.139891109421377
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.139801215846119
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.13979472679815
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.139772994517144
"Section II Overview of CY 2019 Benefits and Bid Review","Section III CY 2019 Formulary Submission Window",0.139761208499199
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Innovations in Health Plan Design",0.139682299380882
"Section II Tiered Cost Sharing of Medical Benefits","Section B.  Calculation of Fee for Service Cost",0.139537183266936
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.139502022199165
"Section II Employer Group Waiver Plans","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.139139076188746
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section C.  IME Phase Out",0.138855335933126
"Section II Overview of CY 2019 Benefits and Bid Review","Section A.  Update of the RxHCC Model",0.138844838073804
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.138826416775063
"Section III Benefit Review","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.138735068556653
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Incomplete and Inaccurate Bid Submissions",0.138677316822704
"Section O.  Quality Payment Program","Section I Incomplete and Inaccurate Bid Submissions",0.138642265008962
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section G.  MA Employer Group Waiver Plans",0.1385305460525
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Plans with Low Enrollment",0.138264710533146
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Transparency   Timeliness with Prior Authorization Processes",0.138247907798128
"Section III Expanding the Part D OTC Program","Section I Incomplete and Inaccurate Bid Submissions",0.138151137391467
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.138138744896933
"Section III Coordination of Benefits (COB) User Fee","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.137727172902725
"Section III Coordination of Benefits (COB) User Fee","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.13763933566428
"Section III Tier Composition","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.137607155548271
"Section II Part C Optional Supplemental Benefits","Section B.  Calculation of Fee for Service Cost",0.137206557411505
"Section II Cost Plan Transition to MA under MACRA","Section B.  Calculation of Fee for Service Cost",0.137120224717856
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.137098408526625
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Maximum Out of Pocket (MOOP) Limits",0.137031722864081
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Total Beneficiary Cost (TBC)",0.136870420075253
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section I Validation Audits",0.13685477991377
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Validation Audits",0.13650185771508
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.136440613774477
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section B.  FFS Growth Percentage",0.136412086760036
"Section I Validation Audits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.136181312983294
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Improving Access to Part D Vaccines",0.136140594894283
"Section I Innovations in Health Plan Design","Section I.  ESRD Risk Adjustment Model for CY 2019",0.13602003555199
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.135636358943518
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.1356276360676
"Section IV   Medicare Medicaid Plans","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.135594410041415
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section B.  Calculation of Fee for Service Cost",0.135451464137119
"Section II Plans with Low Enrollment","Section II Total Beneficiary Cost (TBC)",0.135448119078897
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Cost Plan Transition to MA under MACRA",0.13538571949502
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I.  ESRD Risk Adjustment Model for CY 2019",0.134834529237578
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Plans with Low Enrollment",0.134323135112067
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.134151811851104
"Section II Cost Plan Transition to MA under MACRA","Section III Expanding the Part D OTC Program",0.134081802673916
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Incomplete and Inaccurate Bid Submissions",0.133902298975622
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section III Low Enrollment Plans (Stand alone PDPs only)",0.133897654991228
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section G.  MA Employer Group Waiver Plans",0.133855431219161
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.133808956506282
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.133729569967146
"Section II Plans with Low Enrollment","Section B.  Calculation of Fee for Service Cost",0.133654210104838
"Section I Annual Calendar","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.133581028780603
"Section II Outpatient Observation Services","Section II Cost Plan Transition to MA under MACRA",0.133484443387256
"Section I Innovations in Health Plan Design","Section II Health Related Supplemental Benefits",0.133435247254602
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Advantage (MA) Segmented Service Area Options",0.133421291724697
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Low Enrollment Plans (Stand alone PDPs only)",0.133356438811114
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.133246601538705
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section E.  Clinical Trials",0.133027099919437
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section I.  ESRD Risk Adjustment Model for CY 2019",0.132996399924612
"Section II Cost Plan Competition Requirements","Section C.  IME Phase Out",0.132986698087667
"Section II Employer Group Waiver Plans","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.13285951260282
"Section II Employer Group Waiver Plans","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.132678533159673
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Expanding the Part D OTC Program",0.132665117811772
"Section II Tiered Cost Sharing of Medical Benefits","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.132635010392048
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section C.  Part D Risk Sharing",0.132616089890221
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.132577964183286
"Section III Benefit Review","Section III CY 2019 Formulary Submission Window",0.132564028896689
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Part C Optional Supplemental Benefits",0.132493457150967
"Section D.  Retiree Drug Subsidy Amounts","Section III Expanding the Part D OTC Program",0.132404984917789
"Section II Part C Optional Supplemental Benefits","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.132249240841805
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Tier Composition",0.132182112418734
"Section III Benefit Review","Section B.  Calculation of Fee for Service Cost",0.132123159026114
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.132059238553495
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section IV   Medicare Medicaid Plans",0.131963506530239
"Section I Incomplete and Inaccurate Bid Submissions","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.131895120800014
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section B.  Calculation of Fee for Service Cost",0.131821586912693
"Section III Benefit Review","Section I Incomplete and Inaccurate Bid Submissions",0.131582605276865
"Section III Benefit Review","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.131468439624436
"Section III Expanding the Part D OTC Program","Section E.  Clinical Trials",0.131390677636365
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section O.  Quality Payment Program",0.131296353436619
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Validation Audits",0.131289356486153
"Section A.  MA Growth Percentage","Section D.  ESRD Rates",0.131173177068644
"Section II Part C Optional Supplemental Benefits","Section II Maximum Out of Pocket (MOOP) Limits",0.131062441767726
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.130804579586677
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Plan Corrections",0.130766445241485
"Section I Annual Calendar","Section II Outpatient Observation Services",0.130677093372329
"Section I Annual Calendar","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.130416319357614
"Section II Employer Group Waiver Plans","Section II Transparency   Timeliness with Prior Authorization Processes",0.130332576899734
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.130293054175511
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section D.  Retiree Drug Subsidy Amounts",0.130207151108546
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Innovations in Health Plan Design",0.130005199151858
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.12996515260007
"Section II Employer Group Waiver Plans","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.129964253503717
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.12978488178791
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.129765379429449
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Maximum Out of Pocket (MOOP) Limits",0.129706159269155
"Section C.  IME Phase Out","Section II Tiered Cost Sharing of Medical Benefits",0.129683321067031
"Section III Specialty Tiers","Section IV   Medicare Medicaid Plans",0.129658704223536
"Section II Plans with Low Enrollment","Section II Maximum Out of Pocket (MOOP) Limits",0.129552205316656
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Low Enrollment Plans (Stand alone PDPs only)",0.1295224567651
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.129431776683564
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.1292462131009
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.1292395302489
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section K.  Medicare Advantage Coding Pattern Adjustment",0.129226950529226
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III CY 2019 Formulary Submission Window",0.128963926956193
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section IV   Medicare Medicaid Plans",0.128858119219179
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.12881416098919
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.12880521987674
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.128766038630126
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section IV   Medicare Medicaid Plans",0.128725079727652
"Section I Annual Calendar","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.128706650221748
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Cost Plan Transition to MA under MACRA",0.128671992864137
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.128585065046599
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Maximum Out of Pocket (MOOP) Limits",0.128562442227716
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Transparency   Timeliness with Prior Authorization Processes",0.128404274891606
"Section O.  Quality Payment Program","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.128291853823479
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.128194228765847
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.128139258274459
"Section III Benefit Review","Section A.  Update of the RxHCC Model",0.128109017702511
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Part C Cost Sharing Standards",0.127980507493535
"Section III Tier Composition","Section I Incomplete and Inaccurate Bid Submissions",0.127978757843349
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D.  ESRD Rates",0.127945244229023
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section E.  Clinical Trials",0.12772633330472
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.127473894426098
"Section I Annual Calendar","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.12744414260967
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.127389239778815
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B.  FFS Growth Percentage",0.127307109356691
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.127223061111186
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section C.  IME Phase Out",0.127192600149779
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Incomplete and Inaccurate Bid Submissions",0.127047216512625
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Tier Composition",0.126806863207137
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section B.  Calculation of Fee for Service Cost",0.126747530132966
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.126488954439049
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.126376952868782
"Section III Coordination of Benefits (COB) User Fee","Section II Overview of CY 2019 Benefits and Bid Review",0.126335190073285
"Section I Validation Audits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.126334515379364
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section A.  Update of the RxHCC Model",0.126317194943763
"Section III Expanding the Part D OTC Program","Section II Maximum Out of Pocket (MOOP) Limits",0.126284070395095
"Section II Transparency   Timeliness with Prior Authorization Processes","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.12617488583663
"Section I Innovations in Health Plan Design","Section III CY 2019 Formulary Submission Window",0.12617101552572
"Section III Coordination of Benefits (COB) User Fee","Section A.  Update of the RxHCC Model",0.126157544478607
"Section II Employer Group Waiver Plans","Section D.  Retiree Drug Subsidy Amounts",0.126155140059354
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.126130547149167
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Improving Access to Part D Vaccines",0.126095187553451
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Expanding the Part D OTC Program",0.126068226414825
"Section II Cost Plan Transition to MA under MACRA","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.126017090534441
"Section III Improving Access to Part D Vaccines","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.125980697062546
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section I Incomplete and Inaccurate Bid Submissions",0.125871305904584
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.125841763923324
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.125801049688338
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section L.  Normalization Factors",0.12576300336115
"Section I Plan Corrections","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.125730741985364
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Expanding the Part D OTC Program",0.12572275152356
"Section D.  ESRD Rates","Section O.  Quality Payment Program",0.125655437372709
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.12547089696491
"Section II Employer Group Waiver Plans","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.125442393451311
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Maximum Out of Pocket (MOOP) Limits",0.125438750599885
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section B.  FFS Growth Percentage",0.125410125310983
"Section II Tiered Cost Sharing of Medical Benefits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.125268867385914
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.125208501569779
"Section I Plan Corrections","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.125205471472001
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.125090539546111
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.125051742450363
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.124942711572
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section C.  Part D Risk Sharing",0.124772124279995
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section K.  Medicare Advantage Coding Pattern Adjustment",0.124752719836961
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section G.  MA Employer Group Waiver Plans",0.124731630993416
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Validation Audits",0.124637959311026
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Health Related Supplemental Benefits",0.124480262133134
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.124445926153516
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.124392588125967
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.124250172865549
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III CY 2019 Formulary Submission Window",0.124211795661099
"Section I Annual Calendar","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.12392868793407
"Section II Plans with Low Enrollment","Section II Part C Cost Sharing Standards",0.123896306601118
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Total Beneficiary Cost (TBC)",0.123730976989259
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Validation Audits",0.12350665439963
"Section I Enforcement Actions for Provider Directories","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.123481343882978
"Section III Specialty Tiers","Section II Cost Plan Competition Requirements",0.123331072707331
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.123305405903453
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Innovations in Health Plan Design",0.123062100498506
"Section I Annual Calendar","Section I Validation Audits",0.122874003485128
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.122716126815645
"Section II Outpatient Observation Services","Section B.  Calculation of Fee for Service Cost",0.122631494195432
"Section A.  Update of the RxHCC Model","Section III CY 2019 Formulary Submission Window",0.12234810582269
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section E.  Clinical Trials",0.122316031756484
"Section C.  Part D Risk Sharing","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.122144052070742
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Overview of CY 2019 Benefits and Bid Review",0.122085640473322
"Section II Part C Cost Sharing Standards","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.121870002057452
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Health Related Supplemental Benefits",0.121825379813514
"Section III Coordination of Benefits (COB) User Fee","Section I Incomplete and Inaccurate Bid Submissions",0.12153390275535
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.121515390820552
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Plan Corrections",0.121443509944252
"Section I Annual Calendar","Section I Innovations in Health Plan Design",0.121409126989654
"Section I Innovations in Health Plan Design","Section II Part C Cost Sharing Standards",0.121171841332062
"Section D.  ESRD Rates","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.121109252733479
"Section II Cost Plan Transition to MA under MACRA","Section G.  MA Employer Group Waiver Plans",0.120949879017416
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Meaningful Difference (Substantially Duplicative Plan Offerings)",0.120753708621369
"Section II Part C Optional Supplemental Benefits","Section II Tiered Cost Sharing of Medical Benefits",0.120690594255657
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Innovations in Health Plan Design",0.120659395481352
"Section I Annual Calendar","Section I Enforcement Actions for Provider Directories",0.120640914239735
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Expanding the Part D OTC Program",0.120624477409291
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.120595116705611
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Annual Calendar",0.120548397630414
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.120523130776382
"Section III Expanding the Part D OTC Program","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.12043319835089
"Section II Transparency   Timeliness with Prior Authorization Processes","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.120402568467903
"Section II Employer Group Waiver Plans","Section B.  FFS Growth Percentage",0.120401341777128
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Coordination of Benefits (COB) User Fee",0.120378110981315
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section C.  Part D Risk Sharing",0.120322072496876
"Section III Improving Access to Part D Vaccines","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.120184579408971
"Section II Part C Optional Supplemental Benefits","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.120129149684327
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.120107465821755
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.120070718464681
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Maximum Out of Pocket (MOOP) Limits",0.120025253644336
"Section III Specialty Tiers","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.1199319733582
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Total Beneficiary Cost (TBC)",0.119646293224832
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Total Beneficiary Cost (TBC)",0.11961384237172
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section O.  Quality Payment Program",0.119592820173018
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Part C Cost Sharing Standards",0.119563646573076
"Section C.  IME Phase Out","Section B.  Encounter Data as a Diagnosis Source for 2019",0.119446098821236
"Section II Health Related Supplemental Benefits","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.11938985711932
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Innovations in Health Plan Design",0.1193449624018
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.119299080705277
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Innovations in Health Plan Design",0.119240912195376
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.119227524428784
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Total Beneficiary Cost (TBC)",0.119207968940789
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.119120024756604
"Section II Transparency   Timeliness with Prior Authorization Processes","Section O.  Quality Payment Program",0.119052021902183
"Section II Total Beneficiary Cost (TBC)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.118922415368634
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.118868792569679
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.118797224431948
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section A.  Update of the RxHCC Model",0.118678810702521
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.118468053823695
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Medicare Advantage (MA) Uniformity Flexibility",0.118401970225177
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E.  Clinical Trials",0.118147497569826
"Section I Annual Calendar","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.118141257988695
"Section I Annual Calendar","Section III Low Enrollment Plans (Stand alone PDPs only)",0.11805291565576
"Section IV   Medicare Medicaid Plans","Section I Validation Audits",0.118030858293751
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section C.  IME Phase Out",0.11802738162699
"Section I Incomplete and Inaccurate Bid Submissions","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.117989693549054
"Section I Enforcement Actions for Provider Directories","Section IV   Medicare Medicaid Plans",0.11794749231069
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section B.  Calculation of Fee for Service Cost",0.117777662624707
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Health Related Supplemental Benefits",0.117745831388313
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Medicare Advantage (MA) Segmented Service Area Options",0.117701374181374
"Section II Cost Plan Transition to MA under MACRA","Section I Plan Corrections",0.117655201333753
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section B.  Calculation of Fee for Service Cost",0.117595777911175
"Section III Coordination of Benefits (COB) User Fee","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.117467426090553
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.117462240567885
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.117381097739595
"Section II Plans with Low Enrollment","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.117234665192811
"Section I Enforcement Actions for Provider Directories","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.11721559658586
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section A.  Update of the RxHCC Model",0.117153825551904
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Total Beneficiary Cost (TBC)",0.117133928031086
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.116953352321612
"Section II Outpatient Observation Services","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.116817328378999
"Section I Innovations in Health Plan Design","Section IV   Medicare Medicaid Plans",0.116768594883485
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section L.  Normalization Factors",0.11658428189287
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section A.  Update of the RxHCC Model",0.116568278135557
"Section I Innovations in Health Plan Design","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.116548176498245
"Section III Expanding the Part D OTC Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.11650202055969
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Low Enrollment Plans (Stand alone PDPs only)",0.116065497646527
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section O.  Quality Payment Program",0.1160380449155
"Section A.  Update of the RxHCC Model","Section III Expanding the Part D OTC Program",0.115974248278805
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I Validation Audits",0.115921143248957
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section K.  Medicare Advantage Coding Pattern Adjustment",0.115920875200347
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Incomplete and Inaccurate Bid Submissions",0.11573356095139
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Incomplete and Inaccurate Bid Submissions",0.115700835009036
"Section I Annual Calendar","Section B.  Calculation of Fee for Service Cost",0.115641487139292
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Overview of CY 2019 Benefits and Bid Review",0.11558018266967
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section C.  IME Phase Out",0.115478045674723
"Section II Outpatient Observation Services","Section II Total Beneficiary Cost (TBC)",0.115222292167693
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.115199626525259
"Section III Tier Composition","Section II Maximum Out of Pocket (MOOP) Limits",0.115098559808908
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.114866844030782
"Section II Cost Plan Competition Requirements","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.114851844355413
"Section II Cost Plan Competition Requirements","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.114434520491596
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section B.  FFS Growth Percentage",0.11439729110422
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Validation Audits",0.114360965546598
"Section II Part C Cost Sharing Standards","Section III CY 2019 Formulary Submission Window",0.114350007282575
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.114306202864396
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section I Incomplete and Inaccurate Bid Submissions",0.114285188902835
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.114204082183301
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section I Validation Audits",0.114159653569747
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Tier Composition",0.11411867364186
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Annual Calendar",0.114110551393159
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section D.  ESRD Rates",0.114075613078364
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.113697369101713
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section B.  Calculation of Fee for Service Cost",0.113648196395856
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.113560160904369
"Section II Part C Optional Supplemental Benefits","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.113558902176802
"Section I Innovations in Health Plan Design","Section I Validation Audits",0.113537667760589
"Section II Plans with Low Enrollment","Section I Incomplete and Inaccurate Bid Submissions",0.113437136963636
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section IV   Medicare Medicaid Plans",0.113318186211568
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.113271852167055
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.113223462199962
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.113215096426525
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section G.  MA Employer Group Waiver Plans",0.113104228962757
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.113081876041869
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Total Beneficiary Cost (TBC)",0.113071835928688
"Section II Plans with Low Enrollment","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.112923047720204
"Section II Transparency   Timeliness with Prior Authorization Processes","Section M.  Medical Loss Ratio Credibility Adjustment",0.112915577123928
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.11282661216669
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Medicare Advantage (MA) Segmented Service Area Options",0.112672561520606
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.112671361404534
"Section B.  FFS Growth Percentage","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.112630755703697
"Section D.  Retiree Drug Subsidy Amounts","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.11262666742019
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section B.  Calculation of Fee for Service Cost",0.112576545050632
"Section II Overview of CY 2019 Benefits and Bid Review","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.112549895785468
"Section E.  Clinical Trials","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.112447650692911
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Health Related Supplemental Benefits",0.112447043009619
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Validation Audits",0.112224149687159
"Section A.  Update of the RxHCC Model","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.112045634844088
"Section II Outpatient Observation Services","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.111934903773013
"Section II Overview of CY 2019 Benefits and Bid Review","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.11155719429129
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.111515086075245
"Section II Plans with Low Enrollment","Section IV   Medicare Medicaid Plans",0.111476096301677
"Section III Coordination of Benefits (COB) User Fee","Section II Medicare Advantage (MA) Uniformity Flexibility",0.111292430127454
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Innovations in Health Plan Design",0.111203967218388
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.11118993780284
"Section II Part C Optional Supplemental Benefits","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.11115158926296
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.111005588592719
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.110991204546354
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Annual Calendar",0.110965295941843
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.110935666201417
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Cost Plan Competition Requirements",0.110862540081382
"Section II Health Related Supplemental Benefits","Section III CY 2019 Formulary Submission Window",0.11084843127481
"Section II Overview of CY 2019 Benefits and Bid Review","Section C.  IME Phase Out",0.110701369381903
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section G.  MA Employer Group Waiver Plans",0.110595380833976
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.11055968780111
"Section C.  IME Phase Out","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.110536545395023
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.110524230085282
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.110522683028762
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.110445813589689
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.110398518508511
"Section II Part C Cost Sharing Standards","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.110397539110191
"Section II Part C Optional Supplemental Benefits","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.110339579692946
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Cost Plan Transition to MA under MACRA",0.110261351928018
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.110196210683001
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Maximum Out of Pocket (MOOP) Limits",0.110027722197071
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.109993769610265
"Section II Tiered Cost Sharing of Medical Benefits","Section I Innovations in Health Plan Design",0.109965450867672
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Total Beneficiary Cost (TBC)",0.109743814039972
"Section III Improving Access to Part D Vaccines","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.109583433428779
"Section III Improving Access to Part D Vaccines","Section C.  Part D Risk Sharing",0.109479133279028
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Specialty Tiers",0.109457891610321
"Section III Specialty Tiers","Section I Incomplete and Inaccurate Bid Submissions",0.109357935936184
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Plan Corrections",0.109002646799572
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.10884530971982
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.108748038278826
"Section III Specialty Tiers","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.108233547842559
"Section O.  Quality Payment Program","Section E.  Clinical Trials",0.108220678467013
"Section D.  ESRD Rates","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.108169513665638
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.10809840910984
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section G.  MA Employer Group Waiver Plans",0.107979072716459
"Section O.  Quality Payment Program","Section I.  ESRD Risk Adjustment Model for CY 2019",0.107944642114329
"Section I Enforcement Actions for Provider Directories","Section I Plan Corrections",0.107942607993265
"Section II Health Related Supplemental Benefits","Section B.  Calculation of Fee for Service Cost",0.107851431608001
"Section I Enforcement Actions for Provider Directories","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.107845598115132
"Section II Part C Optional Supplemental Benefits","Section III Improving Access to Part D Vaccines",0.107762422265147
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.10774700984184
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Validation Audits",0.10771089707241
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section C.  IME Phase Out",0.107611577538303
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.107560923997701
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.107463828451862
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section B.  Calculation of Fee for Service Cost",0.107308157643405
"Section O.  Quality Payment Program","Section IV   Medicare Medicaid Plans",0.107303201547072
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.107300347164226
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Cost Plan Transition to MA under MACRA",0.107222192849502
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section II Health Related Supplemental Benefits",0.107172336501705
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.10716377718925
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section I Validation Audits",0.107157536288402
"Section E.  Clinical Trials","Section B.  Calculation of Fee for Service Cost",0.106964850007758
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.10692160559068
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section L.  Normalization Factors",0.106737497737736
"Section D.  ESRD Rates","Section II Part C Cost Sharing Standards",0.106656199094506
"Section II Part C Optional Supplemental Benefits","Section III Coordination of Benefits (COB) User Fee",0.106595100894409
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III CY 2019 Formulary Submission Window",0.106354632744411
"Section II Outpatient Observation Services","Section D.  ESRD Rates",0.10633218075125
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section E.  Clinical Trials",0.106310600603058
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.106292976422535
"Section I Innovations in Health Plan Design","Section III Improving Access to Part D Vaccines",0.106215338244462
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section III CY 2019 Formulary Submission Window",0.106164615391472
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.106056865630075
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Innovations in Health Plan Design",0.106050482499445
"Section III Specialty Tiers","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.106004699185731
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.106000731546731
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Plans with Low Enrollment",0.105768790729671
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section G.  MA Employer Group Waiver Plans",0.105738156782807
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section G.  MA Employer Group Waiver Plans",0.105335784252124
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.105214844250869
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.105066231687911
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section I Incomplete and Inaccurate Bid Submissions",0.105036684603391
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section IV   Medicare Medicaid Plans",0.104988749715752
"Section I Enforcement Actions for Provider Directories","Section E.  Clinical Trials",0.104969718878493
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.104860151448213
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Expanding the Part D OTC Program",0.104840485330445
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section III CY 2019 Formulary Submission Window",0.104838438357221
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section IV   Medicare Medicaid Plans",0.104811150302771
"Section II Plans with Low Enrollment","Section II Tiered Cost Sharing of Medical Benefits",0.104630704352896
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section G.  MA Employer Group Waiver Plans",0.104589442836613
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section IV   Medicare Medicaid Plans",0.104574584923808
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section C.  IME Phase Out",0.104272949906246
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.104183292453773
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section G.  MA Employer Group Waiver Plans",0.104142067362205
"Section III Coordination of Benefits (COB) User Fee","Section II Transparency   Timeliness with Prior Authorization Processes",0.104125838756167
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.104115841259071
"Section II Plans with Low Enrollment","Section I Validation Audits",0.104102471748072
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.103925775502261
"Section II Overview of CY 2019 Benefits and Bid Review","Section M.  Medical Loss Ratio Credibility Adjustment",0.103909770851571
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Low Enrollment Plans (Stand alone PDPs only)",0.103881265847683
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.103826135864681
"Section A.  Update of the RxHCC Model","Section O.  Quality Payment Program",0.103801438972629
"Section I Enforcement Actions for Provider Directories","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.103684176064656
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.103640139224643
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.103517258980939
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section C.  Part D Risk Sharing",0.103475815194851
"Section B.  FFS Growth Percentage","Section A.  Update of the RxHCC Model",0.103467808638742
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Innovations in Health Plan Design",0.103463170081443
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Maximum Out of Pocket (MOOP) Limits",0.103423353720125
"Section II Cost Plan Competition Requirements","Section D.  ESRD Rates",0.103319324397024
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section I.  ESRD Risk Adjustment Model for CY 2019",0.103277989666589
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section A.  Update of the RxHCC Model",0.103175555809602
"Section II Cost Plan Transition to MA under MACRA","Section II Health Related Supplemental Benefits",0.103006351647981
"Section III Specialty Tiers","Section II Part C Cost Sharing Standards",0.102947895356873
"Section III Specialty Tiers","Section D.  Retiree Drug Subsidy Amounts",0.102752466547518
"Section III Benefit Review","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.102677808589751
"Section A.  Update of the RxHCC Model","Section III Tier Composition",0.102660457135164
"Section II Tiered Cost Sharing of Medical Benefits","Section I Incomplete and Inaccurate Bid Submissions",0.102586192991699
"Section B.  Calculation of Fee for Service Cost","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.102525928559365
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.102498419494565
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section IV   Medicare Medicaid Plans",0.102453799687211
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section B.  Calculation of Fee for Service Cost",0.102412162451421
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section M.  Medical Loss Ratio Credibility Adjustment",0.102360431492277
"Section I Plan Corrections","Section II Health Related Supplemental Benefits",0.102279499135855
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section G.  MA Employer Group Waiver Plans",0.102213182584449
"Section II Health Related Supplemental Benefits","Section G.  MA Employer Group Waiver Plans",0.102209502126138
"Section E.  Clinical Trials","Section I.  ESRD Risk Adjustment Model for CY 2019",0.102092540474465
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section B.  Calculation of Fee for Service Cost",0.102082570276849
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.102058927357252
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.1020272965098
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section C.  IME Phase Out",0.101997827288359
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section D.  Retiree Drug Subsidy Amounts",0.101984639720376
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section C.  IME Phase Out",0.101735514945754
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I.  ESRD Risk Adjustment Model for CY 2019",0.101672338864355
"Section I Plan Corrections","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.101591694096
"Section B.  FFS Growth Percentage","Section B.  Encounter Data as a Diagnosis Source for 2019",0.101570249490691
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.101506261224462
"Section II Cost Plan Competition Requirements","Section G.  MA Employer Group Waiver Plans",0.101468091599943
"Section II Cost Plan Competition Requirements","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.10146058374889
"Section II Cost Plan Competition Requirements","Section I Innovations in Health Plan Design",0.101458199759622
"Section II Part C Cost Sharing Standards","Section I.  ESRD Risk Adjustment Model for CY 2019",0.101355737247292
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Expanding the Part D OTC Program",0.10135192974011
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.101311626897892
"Section III Coordination of Benefits (COB) User Fee","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.101257038900785
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Incomplete and Inaccurate Bid Submissions",0.101241650556029
"Section O.  Quality Payment Program","Section II Part C Cost Sharing Standards",0.10116858903956
"Section III Improving Access to Part D Vaccines","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.100971762611233
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Improving Access to Part D Vaccines",0.100911201109365
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section III CY 2019 Formulary Submission Window",0.100753219448756
"Section I Annual Calendar","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.100741127123089
"Section III Specialty Tiers","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.100734578018169
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.100720776752197
"Section II Plans with Low Enrollment","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.100671606309931
"Section I Plan Corrections","Section II Part C Cost Sharing Standards",0.100617094008017
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.100535725350932
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Transparency   Timeliness with Prior Authorization Processes",0.100500903039818
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Total Beneficiary Cost (TBC)",0.100490519005999
"Section III Specialty Tiers","Section I Validation Audits",0.100477730263564
"Section I Innovations in Health Plan Design","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.100444826879598
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.100345113955162
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III CY 2019 Formulary Submission Window",0.100332931016061
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.100318381085973
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section G.  MA Employer Group Waiver Plans",0.100309985780603
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.100204698871905
"Section II Outpatient Observation Services","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.100190626338525
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.100143495957512
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Transparency   Timeliness with Prior Authorization Processes",0.100093621615887
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section O.  Quality Payment Program",0.10004319873317
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0999685068534685
"Section I Enforcement Actions for Provider Directories","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0998511137008569
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0997732734117848
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Incomplete and Inaccurate Bid Submissions",0.0997495239595798
"Section IV   Medicare Medicaid Plans","Section G.  MA Employer Group Waiver Plans",0.0996786589890259
"Section II Overview of CY 2019 Benefits and Bid Review","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0995409640995564
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.099485783451735
"Section II Part C Optional Supplemental Benefits","Section III CY 2019 Formulary Submission Window",0.0994547515953443
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0994176118174777
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B.  Calculation of Fee for Service Cost",0.0993580632239224
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Incomplete and Inaccurate Bid Submissions",0.0992647253437575
"Section II Part C Optional Supplemental Benefits","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0992616937491431
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Total Beneficiary Cost (TBC)",0.0992376169680514
"Section III Coordination of Benefits (COB) User Fee","Section II Total Beneficiary Cost (TBC)",0.0992376169680514
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0992360812516924
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0991875248954666
"Section III Coordination of Benefits (COB) User Fee","Section E.  Clinical Trials",0.0991644699311128
"Section E.  Clinical Trials","Section I Incomplete and Inaccurate Bid Submissions",0.0990737603513598
"Section C.  Part D Risk Sharing","Section B.  Calculation of Fee for Service Cost",0.0990736304703229
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0990647910765376
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section B.  Calculation of Fee for Service Cost",0.0990385851360518
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0990147542976674
"Section III Coordination of Benefits (COB) User Fee","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0989664853222947
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0988936352868298
"Section II Part C Optional Supplemental Benefits","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0987836526581157
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0987263003884569
"Section A.  Update of the RxHCC Model","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0986698761668856
"Section II Cost Plan Transition to MA under MACRA","Section O.  Quality Payment Program",0.0986429706685814
"Section I Plan Corrections","Section III Tier Composition",0.0986369452342919
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Plan Corrections",0.0984671787493708
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section IV   Medicare Medicaid Plans",0.0981535448279781
"Section I Innovations in Health Plan Design","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0981052578480157
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0980865316772568
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0980590749201213
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section D.  ESRD Rates",0.0979994992959272
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Tiered Cost Sharing of Medical Benefits",0.0977384111188479
"Section II Part C Optional Supplemental Benefits","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0977121758198748
"Section II Cost Plan Competition Requirements","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0977043427826385
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0975839849042274
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0975766468483812
"Section III Improving Access to Part D Vaccines","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.097543458872709
"Section A.  MA Growth Percentage","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0975324490431374
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0974964799952955
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Validation Audits",0.0974846114560493
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III CY 2019 Formulary Submission Window",0.097466661000461
"Section II Part C Optional Supplemental Benefits","Section C.  Part D Risk Sharing",0.0973828979981871
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section O.  Quality Payment Program",0.0973596715114606
"Section I Annual Calendar","Section M.  Medical Loss Ratio Credibility Adjustment",0.097302983539912
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section E.  Clinical Trials",0.0971939486332928
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section O.  Quality Payment Program",0.0971669327542425
"Section E.  Clinical Trials","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.097147810533645
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Transparency   Timeliness with Prior Authorization Processes",0.0969166528250333
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0968672146104885
"Section II Cost Plan Competition Requirements","Section O.  Quality Payment Program",0.0967887025975722
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0966859436583875
"Section B.  FFS Growth Percentage","Section M.  Medical Loss Ratio Credibility Adjustment",0.0966522668153957
"Section III Coordination of Benefits (COB) User Fee","Section B.  Calculation of Fee for Service Cost",0.096561628245147
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section G.  MA Employer Group Waiver Plans",0.0964866627031325
"Section II Total Beneficiary Cost (TBC)","Section I Validation Audits",0.0964096186032618
"Section II Transparency   Timeliness with Prior Authorization Processes","Section C.  IME Phase Out",0.0963297121838401
"Section I Enforcement Actions for Provider Directories","Section I Validation Audits",0.0963224740793367
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section B.  Calculation of Fee for Service Cost",0.0962835475513579
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.096265447171874
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III Expanding the Part D OTC Program",0.0962426231053183
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section IV   Medicare Medicaid Plans",0.0961227657745622
"Section D.  Retiree Drug Subsidy Amounts","Section B.  Calculation of Fee for Service Cost",0.0961083444540818
"Section II Overview of CY 2019 Benefits and Bid Review","Section D.  ESRD Rates",0.095999619598515
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Plan Corrections",0.0959925402981483
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Improving Access to Part D Vaccines",0.0959682851246179
"Section C.  IME Phase Out","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0959407534636126
"Section III Benefit Review","Section III Coordination of Benefits (COB) User Fee",0.0958486021002659
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0958422866061798
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0958245412152993
"Section II Tiered Cost Sharing of Medical Benefits","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0957853279784427
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0957105448228677
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I Innovations in Health Plan Design",0.0956938269710531
"Section III Benefit Review","Section C.  IME Phase Out",0.0956920934256642
"Section C.  IME Phase Out","Section II Plans with Low Enrollment",0.0955216710403186
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0954955673754808
"Section III Benefit Review","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0954183943682449
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0953929920015966
"Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs","Section G.  MA Employer Group Waiver Plans",0.0953482570725964
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section M.  Medical Loss Ratio Credibility Adjustment",0.0953005256456033
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Tier Composition",0.0952386570521186
"Section II Employer Group Waiver Plans","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0952287650303591
"Section I Enforcement Actions for Provider Directories","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0952214496720042
"Section III Improving Access to Part D Vaccines","Section II Health Related Supplemental Benefits",0.0951143774882967
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section B.  FFS Growth Percentage",0.0951087834401835
"Section II Maximum Out of Pocket (MOOP) Limits","Section I Incomplete and Inaccurate Bid Submissions",0.0950757398977878
"Section II Employer Group Waiver Plans","Section III Improving Access to Part D Vaccines",0.0949198039262698
"Section III Tier Composition","Section II Health Related Supplemental Benefits",0.0948953044940969
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Tier Composition",0.0948870054253305
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0948850215748029
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section A.  Update of the RxHCC Model",0.094870796522408
"Section III Specialty Tiers","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0948344029388927
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0948224501559667
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.094615979753278
"Section III Coordination of Benefits (COB) User Fee","Section II Health Related Supplemental Benefits",0.0944705598633073
"Section I Plan Corrections","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0944244980317851
"Section III Coordination of Benefits (COB) User Fee","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.094392710192184
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Total Beneficiary Cost (TBC)",0.0943813973722443
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0942773916953731
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0942512140601128
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0941574458868477
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0940960302463231
"Section I Annual Calendar","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0940296028218062
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Cost Plan Transition to MA under MACRA",0.0940207402449168
"Section A.  MA Growth Percentage","Section II Overview of CY 2019 Benefits and Bid Review",0.0939955905822795
"Section II Outpatient Observation Services","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0938550591477923
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0938536424569621
"Section II Employer Group Waiver Plans","Section II Outpatient Observation Services",0.0937903091855161
"Section D.  Retiree Drug Subsidy Amounts","Section III CY 2019 Formulary Submission Window",0.0936881626349782
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Health Related Supplemental Benefits",0.0936538658902292
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Innovations in Health Plan Design",0.0936536912643525
"Section D.  ESRD Rates","Section III Improving Access to Part D Vaccines",0.093396595373834
"Section II Outpatient Observation Services","Section III Expanding the Part D OTC Program",0.0932558871191239
"Section III Coordination of Benefits (COB) User Fee","Section II Cost Plan Competition Requirements",0.0932429426227821
"Section M.  Medical Loss Ratio Credibility Adjustment","Section IV   Medicare Medicaid Plans",0.0931539171186183
"Section II Employer Group Waiver Plans","Section E.  Clinical Trials",0.0931504340303955
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Enforcement Actions for Provider Directories",0.0931030718789483
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0929749853326895
"Section II Employer Group Waiver Plans","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0929077409126313
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0927959850381523
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section E.  Clinical Trials",0.0927811853017632
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0927360363634459
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0926414239690597
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Part C Cost Sharing Standards",0.0925116126968481
"Section III Specialty Tiers","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.092441278587981
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Expanding the Part D OTC Program",0.0923869770874312
"Section I Incomplete and Inaccurate Bid Submissions","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0923760567168693
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section O.  Quality Payment Program",0.0923750631480273
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0923694160074542
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0923604103642733
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Incomplete and Inaccurate Bid Submissions",0.0923459625819588
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0923395113045419
"Section III Coordination of Benefits (COB) User Fee","Section II Part C Cost Sharing Standards",0.0922559954744151
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0921737796139119
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Part C Cost Sharing Standards",0.0921374359849686
"Section I Enforcement Actions for Provider Directories","Section I Incomplete and Inaccurate Bid Submissions",0.0920721049523037
"Section II Transparency   Timeliness with Prior Authorization Processes","Section G.  MA Employer Group Waiver Plans",0.0920639905820849
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0920283099496133
"Section II Outpatient Observation Services","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0919930544064563
"Section II Employer Group Waiver Plans","Section O.  Quality Payment Program",0.0919859063723494
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0915502542837275
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0914970806485877
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0914026994596013
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Tiered Cost Sharing of Medical Benefits",0.0912813903848825
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.091229137158758
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.091063831634674
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III CY 2019 Formulary Submission Window",0.0909805175930496
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Plan Corrections",0.0909505193239868
"Section III Specialty Tiers","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0908781150126011
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Expanding the Part D OTC Program",0.0908749594677118
"Section D.  ESRD Rates","Section IV   Medicare Medicaid Plans",0.0907660561615269
"Section A.  Update of the RxHCC Model","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0907579379531004
"Section E.  Clinical Trials","Section G.  MA Employer Group Waiver Plans",0.090700180532923
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0906196461107659
"Section II Transparency   Timeliness with Prior Authorization Processes","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.090616601887649
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section C.  Part D Risk Sharing",0.0904767698214023
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Maximum Out of Pocket (MOOP) Limits",0.0904024915798072
"Section D.  Retiree Drug Subsidy Amounts","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0902566977339474
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section D.  ESRD Rates",0.0901765397152881
"Section D.  Retiree Drug Subsidy Amounts","Section A.  Update of the RxHCC Model",0.0900425036253263
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0900406394462102
"Section III Tier Composition","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0900025858979335
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0898551186244318
"Section III Tier Composition","Section I Validation Audits",0.089819550904814
"Section D.  ESRD Rates","Section I Innovations in Health Plan Design",0.0898098365476183
"Section I Plan Corrections","Section III Expanding the Part D OTC Program",0.0897905957526004
"Section III Benefit Review","Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)",0.0897085227145061
"Section D.  ESRD Rates","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0896856999504021
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section B.  Calculation of Fee for Service Cost",0.0896331428517337
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Improving Access to Part D Vaccines",0.0896070258612297
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Part C Cost Sharing Standards",0.0896030478011381
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0895342573710776
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0894650648829268
"Section III Coordination of Benefits (COB) User Fee","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0894101400067425
"Section O.  Quality Payment Program","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0891575306000359
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0891419710189227
"Section II Cost Plan Transition to MA under MACRA","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0890406222892756
"Section B.  FFS Growth Percentage","Section III Expanding the Part D OTC Program",0.0890190607992874
"Section D.  Retiree Drug Subsidy Amounts","Section III Tier Composition",0.0889923053822475
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III CY 2019 Formulary Submission Window",0.0889648893125339
"Section II Plans with Low Enrollment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0889363272213946
"Section A.  MA Growth Percentage","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.088800284161364
"Section B.  FFS Growth Percentage","Section IV   Medicare Medicaid Plans",0.0887381218720699
"Section II Plans with Low Enrollment","Section A.  Update of the RxHCC Model",0.0886915659605637
"Section A.  MA Growth Percentage","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0886125210661929
"Section A.  Update of the RxHCC Model","Section II Maximum Out of Pocket (MOOP) Limits",0.0885509257127025
"Section I Enforcement Actions for Provider Directories","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0884287024518527
"Section III CY 2019 Formulary Submission Window","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0883296565542115
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section B.  Calculation of Fee for Service Cost",0.0883244653343271
"Section I Plan Corrections","Section O.  Quality Payment Program",0.0883054456730435
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0882296296863049
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Total Beneficiary Cost (TBC)",0.0881103703344449
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0880859077869465
"Section C.  IME Phase Out","Section E.  Clinical Trials",0.088061564594842
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Innovations in Health Plan Design",0.0878132700760172
"Section III Improving Access to Part D Vaccines","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0878117573737634
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0877985134943497
"Section C.  Part D Risk Sharing","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0877804512925847
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section L.  Normalization Factors",0.0877608891777119
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section C.  Part D Risk Sharing",0.0876793065895781
"Section III Expanding the Part D OTC Program","Section B.  Calculation of Fee for Service Cost",0.0874722856924094
"Section III Specialty Tiers","Section A.  Update of the RxHCC Model",0.0874063844012304
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section O.  Quality Payment Program",0.0873906416633443
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section A.  Update of the RxHCC Model",0.0873789168642132
"Section II Outpatient Observation Services","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0873333764609373
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0872974209449169
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III Improving Access to Part D Vaccines",0.0872846163166197
"Section II Cost Plan Competition Requirements","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0872678899771296
"Section II Employer Group Waiver Plans","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.087241385449781
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section C.  IME Phase Out",0.0872410090353458
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Plan Corrections",0.0870844636788582
"Section III Specialty Tiers","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.086940157413114
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0868795080703114
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0865464553477082
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Cost Plan Competition Requirements",0.086425495882102
"Section A.  MA Growth Percentage","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0863908720771138
"Section II Cost Plan Transition to MA under MACRA","Section I Validation Audits",0.0863485043912217
"Section III Coordination of Benefits (COB) User Fee","Section D.  Retiree Drug Subsidy Amounts",0.0862603284109475
"Section III Specialty Tiers","Section I Annual Calendar",0.0862498764651092
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section D.  ESRD Rates",0.0862323840032867
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Plans with Low Enrollment",0.0860625613092224
"Section O.  Quality Payment Program","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.085918758284075
"Section L.  Normalization Factors","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0859032932794367
"Section II Employer Group Waiver Plans","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0858976534396358
"Section II Employer Group Waiver Plans","Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)",0.0857690027870236
"Section D.  Retiree Drug Subsidy Amounts","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0857057627054358
"Section A.  MA Growth Percentage","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0856692753662875
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0856194385176305
"Section III Coordination of Benefits (COB) User Fee","Section C.  IME Phase Out",0.0856048982777143
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0854162843517964
"Section B.  FFS Growth Percentage","Section O.  Quality Payment Program",0.0853489486720375
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.085200883927789
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0851897822958987
"Section O.  Quality Payment Program","Section I Validation Audits",0.0851707567366806
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.085151000055296
"Section II Maximum Out of Pocket (MOOP) Limits","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0850949246584623
"Section III Tier Composition","Section E.  Clinical Trials",0.0850666149045246
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0850649841041786
"Section I Plan Corrections","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0850034960968846
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0850015904743265
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Tiered Cost Sharing of Medical Benefits",0.084937122029356
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0847549969489678
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0843694418277783
"Section II Health Related Supplemental Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0843014944627271
"Section II Employer Group Waiver Plans","Section III Specialty Tiers",0.0842578867568504
"Section A.  Update of the RxHCC Model","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0842022956780099
"Section II Cost Plan Competition Requirements","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0841819203504068
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section I Incomplete and Inaccurate Bid Submissions",0.083896572016326
"Section A.  MA Growth Percentage","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0838528871003227
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section A.  Update of the RxHCC Model",0.083840853424383
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0837936110122142
"Section II Employer Group Waiver Plans","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0837179238667738
"Section C.  Part D Risk Sharing","Section G.  MA Employer Group Waiver Plans",0.083711593248494
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0836629997421152
"Section A.  MA Growth Percentage","Section II Cost Plan Competition Requirements",0.0836276614795337
"Section III Benefit Review","Section B.  FFS Growth Percentage",0.08345761876158
"Section G.  MA Employer Group Waiver Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0834063294727215
"Section III Benefit Review","Section G.  MA Employer Group Waiver Plans",0.0833780964196937
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.08334456087549
"Section D.  ESRD Rates","Section II Maximum Out of Pocket (MOOP) Limits",0.0833319243023463
"Section II Plans with Low Enrollment","Section O.  Quality Payment Program",0.0832791223513105
"Section II Outpatient Observation Services","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0831091894755796
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0830668806796673
"Section A.  MA Growth Percentage","Section C.  Part D Risk Sharing",0.0830497163276544
"Section C.  Part D Risk Sharing","Section I Validation Audits",0.0830218799236472
"Section III Coordination of Benefits (COB) User Fee","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0829889381532519
"Section C.  IME Phase Out","Section I Innovations in Health Plan Design",0.0829453623272546
"Section II Employer Group Waiver Plans","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0829085539900279
"Section II Employer Group Waiver Plans","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0828008681888027
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0827888817604608
"Section II Cost Plan Transition to MA under MACRA","Section A.  Update of the RxHCC Model",0.0827339574661968
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section O.  Quality Payment Program",0.0826121102985418
"Section II Employer Group Waiver Plans","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0825879255185351
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section IV   Medicare Medicaid Plans",0.0825842533723162
"Section D.  Retiree Drug Subsidy Amounts","Section I Incomplete and Inaccurate Bid Submissions",0.0825618946271854
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0825515941019307
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section C.  Part D Risk Sharing",0.0824744021139117
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0824722467759151
"Section II Plans with Low Enrollment","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0824581015876404
"Section C.  IME Phase Out","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0822720263439334
"Section C.  IME Phase Out","Section II Health Related Supplemental Benefits",0.0820815102128807
"Section C.  IME Phase Out","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0820664925698789
"Section II Employer Group Waiver Plans","Section III Coordination of Benefits (COB) User Fee",0.0819027518500842
"Section II Tiered Cost Sharing of Medical Benefits","Section A.  Update of the RxHCC Model",0.0817759140819338
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Innovations in Health Plan Design",0.0817522398354664
"Section II Plans with Low Enrollment","Section III Improving Access to Part D Vaccines",0.0816430216819695
"Section II Part C Optional Supplemental Benefits","Section II Transparency   Timeliness with Prior Authorization Processes",0.0816323832257448
"Section II Employer Group Waiver Plans","Section B.  Calculation of Fee for Service Cost",0.0815588246243446
"Section III Benefit Review","Section C.  Part D Risk Sharing",0.0815532024677328
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0815189062062347
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0815132101016311
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Total Beneficiary Cost (TBC)",0.081467658058354
"Section I Enforcement Actions for Provider Directories","Section III Expanding the Part D OTC Program",0.0814399937732069
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0814189691445611
"Section II Plans with Low Enrollment","Section I Plan Corrections",0.0814171621389419
"Section I Enforcement Actions for Provider Directories","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0813975874377519
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Maximum Out of Pocket (MOOP) Limits",0.0812668713894941
"Section III Specialty Tiers","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0812633530855627
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section A.  Update of the RxHCC Model",0.0812191770070931
"Section II Cost Plan Transition to MA under MACRA","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0811545272502809
"Section III Coordination of Benefits (COB) User Fee","Section I Plan Corrections",0.0811417529755519
"Section II Tiered Cost Sharing of Medical Benefits","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0811278116750569
"Section II Plans with Low Enrollment","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0811188794997434
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section O.  Quality Payment Program",0.0810242219709458
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0810084253143718
"Section II Part C Cost Sharing Standards","Section I Validation Audits",0.0809902391931841
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Health Related Supplemental Benefits",0.0809756777576642
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section L.  Normalization Factors",0.0809617874902098
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Total Beneficiary Cost (TBC)",0.0809445665582223
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0808964634734155
"Section II Outpatient Observation Services","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0808667418503387
"Section II Cost Plan Competition Requirements","Section III Tier Composition",0.0807706884782419
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0807705539936076
"Section III Benefit Review","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0807410347229262
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section D.  ESRD Rates",0.0807408316526794
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section B.  FFS Growth Percentage",0.0807121887690505
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)",0.0807002111817461
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0806361456166243
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.080514811325761
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Validation Audits",0.0804253504574493
"Section II Employer Group Waiver Plans","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0802869902472501
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0802610140944815
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0802524028006911
"Section III Improving Access to Part D Vaccines","Section G.  MA Employer Group Waiver Plans",0.0802230981787078
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section N.  Encounter Data as a Diagnosis Source for 2019",0.08018238179305
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0801345558571263
"Section C.  Part D Risk Sharing","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0801157827234156
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.080101676276149
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0800848558337166
"Section II Employer Group Waiver Plans","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.08001103676628
"Section E.  Clinical Trials","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0799841705306994
"Section A.  MA Growth Percentage","Section A.  Update of the RxHCC Model",0.079959255524987
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section O.  Quality Payment Program",0.0799442634304587
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III CY 2019 Formulary Submission Window",0.079935953978368
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Part C Cost Sharing Standards",0.0799313537630537
"Section II Part C Optional Supplemental Benefits","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0799021797081333
"Section I Innovations in Health Plan Design","Section G.  MA Employer Group Waiver Plans",0.0798658160635159
"Section II Employer Group Waiver Plans","Section III Timely Updates to LIS Status Based on Best Available Evidence",0.0798643458203143
"Section III Benefit Review","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0798595706249925
"Section II Part C Optional Supplemental Benefits","Section O.  Quality Payment Program",0.0798121084590001
"Section II Tiered Cost Sharing of Medical Benefits","Section O.  Quality Payment Program",0.0797819634243053
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0797429225396905
"Section I Annual Calendar","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0796434269634587
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Plans with Low Enrollment",0.0796303332335311
"Section C.  IME Phase Out","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.079490262686449
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A.  Update of the RxHCC Model",0.0794498400460757
"Section D.  ESRD Rates","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0793466737151325
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section O.  Quality Payment Program",0.0792898523322658
"Section I Enforcement Actions for Provider Directories","Section II Cost Plan Competition Requirements",0.0792603241667771
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section III CY 2019 Formulary Submission Window",0.0791788657974616
"Section II Employer Group Waiver Plans","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0790809714919778
"Section I Annual Calendar","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0790260779693599
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0789176904710181
"Section C.  IME Phase Out","Section L.  Normalization Factors",0.0788944258489694
"Section A.  MA Growth Percentage","Section C.  IME Phase Out",0.0788865232385415
"Section III CY 2019 Formulary Submission Window","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0788255437556313
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Innovations in Health Plan Design",0.0788143870938644
"Section I Annual Calendar","Section O.  Quality Payment Program",0.0787842046255143
"Section III Coordination of Benefits (COB) User Fee","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0787566634894087
"Section III Coordination of Benefits (COB) User Fee","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0787010691407076
"Section I Innovations in Health Plan Design","Section I Incomplete and Inaccurate Bid Submissions",0.0786796895684821
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0786452021389525
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Part C Cost Sharing Standards",0.0786132133514006
"Section II Overview of CY 2019 Benefits and Bid Review","Section B.  FFS Growth Percentage",0.0785735740552763
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Cost Plan Transition to MA under MACRA",0.0785674201318386
"Section D.  ESRD Rates","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0785527231769533
"Section II Plans with Low Enrollment","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0785495574063487
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Total Beneficiary Cost (TBC)",0.0784834877554212
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section O.  Quality Payment Program",0.0784631624522391
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0784450857594143
"Section III Tier Composition","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0783873290367675
"Section II Part C Optional Supplemental Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0783084349193831
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0782780968430293
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Validation Audits",0.0782345558169403
"Section C.  Part D Risk Sharing","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.078215816639572
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section G.  MA Employer Group Waiver Plans",0.0782108328933055
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0781181049866351
"Section II Cost Plan Competition Requirements","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0779617780629742
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Plans with Low Enrollment",0.0779554182573139
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0779423253117719
"Section B.  FFS Growth Percentage","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0778708439237884
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section L.  Normalization Factors",0.077733207066812
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Maximum Out of Pocket (MOOP) Limits",0.0777127565235369
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Incomplete and Inaccurate Bid Submissions",0.0776964790190093
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section C.  Part D Risk Sharing",0.0776197909514978
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0775654970911209
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section L.  Normalization Factors",0.0775506435837941
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Improving Access to Part D Vaccines",0.0775391295429622
"Section III Coordination of Benefits (COB) User Fee","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0775244229255061
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0774273045789062
"Section III Tier Composition","Section C.  Part D Risk Sharing",0.0773477559722196
"Section II Health Related Supplemental Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0773039976427436
"Section II Cost Plan Competition Requirements","Section M.  Medical Loss Ratio Credibility Adjustment",0.0772978971064623
"Section II Plans with Low Enrollment","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0772329806317051
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III CY 2019 Formulary Submission Window",0.0772139294378248
"Section II Outpatient Observation Services","Section III Tier Composition",0.0771884401368048
"Section O.  Quality Payment Program","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0771548118143796
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0771479392144181
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section B.  Calculation of Fee for Service Cost",0.0771440804995354
"Section A.  Update of the RxHCC Model","Section I Incomplete and Inaccurate Bid Submissions",0.0771166937292081
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0770736625491692
"Section II Overview of CY 2019 Benefits and Bid Review","Section L.  Normalization Factors",0.0770257173507524
"Section II Outpatient Observation Services","Section C.  IME Phase Out",0.0770234094310274
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Validation Audits",0.077007354517833
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section L.  Normalization Factors",0.0769675471635164
"Section II Part C Optional Supplemental Benefits","Section M.  Medical Loss Ratio Credibility Adjustment",0.0769527239822591
"Section II Employer Group Waiver Plans","Section III CY 2019 Formulary Submission Window",0.0768250813142749
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.0767906628230666
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section C.  IME Phase Out",0.076762754167657
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0767566521682735
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0766902163410803
"Section B.  FFS Growth Percentage","Section II Part C Cost Sharing Standards",0.0766734973383623
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section C.  Part D Risk Sharing",0.0765114010481976
"Section D.  ESRD Rates","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0763683927797003
"Section I Enforcement Actions for Provider Directories","Section II Plans with Low Enrollment",0.0763068065141269
"Section C.  IME Phase Out","Section II Cost Plan Transition to MA under MACRA",0.0762492851663023
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section IV   Medicare Medicaid Plans",0.0762178108786009
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I Plan Corrections",0.0761593579205226
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0761269312576895
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0761044937647232
"Section II Employer Group Waiver Plans","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0760744118093838
"Section III Expanding the Part D OTC Program","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0760661925575842
"Section II Tiered Cost Sharing of Medical Benefits","Section D.  ESRD Rates",0.0759279532450284
"Section II Plans with Low Enrollment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.075911346290011
"Section II Part C Cost Sharing Standards","Section L.  Normalization Factors",0.0758968950470105
"Section C.  IME Phase Out","Section IV   Medicare Medicaid Plans",0.0758584805815859
"Section II Tiered Cost Sharing of Medical Benefits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0758573903060529
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section O.  Quality Payment Program",0.0758570859484061
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section O.  Quality Payment Program",0.0757952207815174
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0757567096584655
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Innovations in Health Plan Design",0.0756181569036832
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0756126799043541
"Section III Benefit Review","Section II Transparency   Timeliness with Prior Authorization Processes",0.0754997425090333
"Section III Tier Composition","Section I Innovations in Health Plan Design",0.0754394352529489
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0754096429058752
"Section D.  ESRD Rates","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0753271171046107
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0752828419842743
"Section I Enforcement Actions for Provider Directories","Section I Innovations in Health Plan Design",0.0752652629864689
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Health Related Supplemental Benefits",0.0752398610571848
"Section II Cost Plan Transition to MA under MACRA","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0752291392857926
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0751569004238725
"Section II Health Related Supplemental Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0751351195281882
"Section III Expanding the Part D OTC Program","Section C.  Part D Risk Sharing",0.07510479780709
"Section A.  MA Growth Percentage","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0750751861504012
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I Incomplete and Inaccurate Bid Submissions",0.0749890070470024
"Section II Cost Plan Competition Requirements","Section A.  Update of the RxHCC Model",0.0749220014918163
"Section II Tiered Cost Sharing of Medical Benefits","Section III CY 2019 Formulary Submission Window",0.0748552941432544
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Specialty Tiers",0.074848118856512
"Section III Benefit Review","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0748396896800228
"Section II Plans with Low Enrollment","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0747893240980745
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Health Related Supplemental Benefits",0.0747017186353237
"Section III Coordination of Benefits (COB) User Fee","Section II Tiered Cost Sharing of Medical Benefits",0.0745883879461175
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section G.  MA Employer Group Waiver Plans",0.0745822775528266
"Section D.  Retiree Drug Subsidy Amounts","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0744918585380722
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0744667390351355
"Section III Coordination of Benefits (COB) User Fee","Section II Cost Plan Transition to MA under MACRA",0.0744646444067152
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0744266287038522
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0743839498573895
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section B.  Calculation of Fee for Service Cost",0.0743507688183281
"Section A.  Update of the RxHCC Model","Section E.  Clinical Trials",0.0742164670323082
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0741949534183025
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0741145033460358
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.074097177800074
"Section III Part D Benefit Parameters for Non Defined Standard Plans","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0740327422919702
"Section I Plan Corrections","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0740174262699188
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0739355269080546
"Section II Employer Group Waiver Plans","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0739035309291179
"Section L.  Normalization Factors","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0738797234901169
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section III Tier Composition",0.0737412666436403
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0737326283775122
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section III Improving Access to Part D Vaccines",0.0736447477346797
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Incomplete and Inaccurate Bid Submissions",0.0736129450607524
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.073598360922483
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section A.  MA Growth Percentage",0.0735214622093808
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section IV   Medicare Medicaid Plans",0.0734497988169589
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section O.  Quality Payment Program",0.0734295707394623
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III CY 2019 Formulary Submission Window",0.0733081952029322
"Section II Cost Plan Transition to MA under MACRA","Section III Tier Composition",0.0732937732613568
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III CY 2019 Formulary Submission Window",0.0732795687507077
"Section II Outpatient Observation Services","Section I Innovations in Health Plan Design",0.0732574901136782
"Section I Incomplete and Inaccurate Bid Submissions","Section B.  Calculation of Fee for Service Cost",0.0732375959512345
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0732070403960706
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section IV   Medicare Medicaid Plans",0.0731710152911313
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section III Tier Composition",0.0731582689058268
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Tiered Cost Sharing of Medical Benefits",0.0730766971669417
"Section III Expanding the Part D OTC Program","Section O.  Quality Payment Program",0.0729846414655123
"Section II Overview of CY 2019 Benefits and Bid Review","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0729469077051957
"Section III Specialty Tiers","Section B.  Calculation of Fee for Service Cost",0.0729333763585259
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Innovations in Health Plan Design",0.0729225837782204
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Total Beneficiary Cost (TBC)",0.0728571205127583
"Section A.  MA Growth Percentage","Section L.  Normalization Factors",0.0727471074184767
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0727372961170765
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0726699370223705
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section L.  Normalization Factors",0.0726509880035368
"Section III Coordination of Benefits (COB) User Fee","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0726325812044225
"Section II Plans with Low Enrollment","Section I Innovations in Health Plan Design",0.0725283590485434
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0724995475068332
"Section III Coordination of Benefits (COB) User Fee","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0724024123205116
"Section I Plan Corrections","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.072358878399653
"Section D.  ESRD Rates","Section C.  Part D Risk Sharing",0.0723498850216541
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Competition Requirements",0.072276043422954
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III CY 2019 Formulary Submission Window",0.0722256241329512
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section L.  Normalization Factors",0.0722080512029178
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0722002318601857
"Section I Plan Corrections","Section III Improving Access to Part D Vaccines",0.0721685880828584
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section L.  Normalization Factors",0.0721310621323686
"Section II Maximum Out of Pocket (MOOP) Limits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0720853943145334
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Validation Audits",0.0720772522591969
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Plans with Low Enrollment",0.0720680643943604
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0718160162538808
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0717514472412864
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0717296582556168
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I Plan Corrections",0.0717066654202552
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Tiered Cost Sharing of Medical Benefits",0.0716756622620429
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0716730717781713
"Section II Health Related Supplemental Benefits","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0716516029033132
"Section II Maximum Out of Pocket (MOOP) Limits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0716101038798166
"Section II Plans with Low Enrollment","Section II Health Related Supplemental Benefits",0.0714879007160794
"Section O.  Quality Payment Program","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.07146798860182
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0713835435357842
"Section II Health Related Supplemental Benefits","Section O.  Quality Payment Program",0.0713437446684031
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Improving Access to Part D Vaccines",0.071252370873756
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section G.  MA Employer Group Waiver Plans",0.0712425628736253
"Section D.  Retiree Drug Subsidy Amounts","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0712344460334599
"Section I Enforcement Actions for Provider Directories","Section II Total Beneficiary Cost (TBC)",0.0711956374330829
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section A.  Update of the RxHCC Model",0.0711723041258917
"Section B.  FFS Growth Percentage","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0711452618263328
"Section II Cost Plan Competition Requirements","Section I Validation Audits",0.0711047712040315
"Section II Outpatient Observation Services","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0710990735947047
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0710426904796918
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0710317285018262
"Section III Tier Composition","Section B.  Calculation of Fee for Service Cost",0.0708929587740007
"Section II Outpatient Observation Services","Section I Incomplete and Inaccurate Bid Submissions",0.0707684718987307
"Section III Improving Access to Part D Vaccines","Section I Validation Audits",0.0707307045751047
"Section II Cost Plan Competition Requirements","Section L.  Normalization Factors",0.0706490764584113
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.070644479934583
"Section C.  IME Phase Out","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0706219519718848
"Section II Cost Plan Competition Requirements","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0705910920932384
"Section II Cost Plan Transition to MA under MACRA","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0705736080792199
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section A.  Update of the RxHCC Model",0.070548752810892
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section C.  Part D Risk Sharing",0.0705421426413865
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section D.  ESRD Rates",0.0705363162424166
"Section II Cost Plan Transition to MA under MACRA","Section III CY 2019 Formulary Submission Window",0.0704196977359795
"Section C.  IME Phase Out","Section III Expanding the Part D OTC Program",0.0703922864792136
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Maximum Out of Pocket (MOOP) Limits",0.0703432717240493
"Section II Plans with Low Enrollment","Section D.  ESRD Rates",0.0702705198326135
"Section I Innovations in Health Plan Design","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0702559703244594
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B.  FFS Growth Percentage",0.0702432958065209
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section B.  Calculation of Fee for Service Cost",0.0701780050341522
"Section A.  MA Growth Percentage","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.070153629280264
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0701108649062841
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.070086511675847
"Section III Tier Composition","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0700051521470302
"Section III Specialty Tiers","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0699677445305415
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section D.  Retiree Drug Subsidy Amounts",0.0699226616912727
"Section M.  Medical Loss Ratio Credibility Adjustment","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0698810015059556
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section G.  MA Employer Group Waiver Plans",0.0698338678557736
"Section II Tiered Cost Sharing of Medical Benefits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0697800104015123
"Section II Plans with Low Enrollment","Section III Expanding the Part D OTC Program",0.0697587158912125
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section M.  Medical Loss Ratio Credibility Adjustment",0.0697240898952155
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Maximum Out of Pocket (MOOP) Limits",0.0696614908659093
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0696597765719191
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Specialty Tiers",0.06960733665189
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0695277095486253
"Section III Specialty Tiers","Section II Cost Plan Transition to MA under MACRA",0.0694503989520176
"Section E.  Clinical Trials","Section L.  Normalization Factors",0.0692742870393265
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section C.  Part D Risk Sharing",0.0689689215739653
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section D.  ESRD Rates",0.068927242572109
"Section I Enforcement Actions for Provider Directories","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0689257082255236
"Section B.  FFS Growth Percentage","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0689161203906497
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0688367978519101
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0688114176333404
"Section II Tiered Cost Sharing of Medical Benefits","Section G.  MA Employer Group Waiver Plans",0.0687659166880569
"Section III CY 2019 Formulary Submission Window","Section G.  MA Employer Group Waiver Plans",0.0687528331524305
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section II Part C Cost Sharing Standards",0.0687258502192898
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.068624407043885
"Section A.  MA Growth Percentage","Section IV   Medicare Medicaid Plans",0.0685548918804705
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Health Related Supplemental Benefits",0.0684344739897637
"Section III Benefit Review","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0684249604186294
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section G.  MA Employer Group Waiver Plans",0.0683928154842873
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Benefit Review",0.0683763458757828
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section B.  FFS Growth Percentage",0.0683124405431059
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Cost Plan Transition to MA under MACRA",0.0682788741998919
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0682494990430586
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section O.  Quality Payment Program",0.068219279809988
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Validation Audits",0.0681850430878803
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Maximum Out of Pocket (MOOP) Limits",0.0680479226122205
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0680289797225958
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section E.  Clinical Trials",0.0679851005072659
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0679164358583479
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Maximum Out of Pocket (MOOP) Limits",0.0678260689851431
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0678174029221574
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section IV   Medicare Medicaid Plans",0.0677859426530895
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0677765417788019
"Section I Innovations in Health Plan Design","Section II Maximum Out of Pocket (MOOP) Limits",0.0677254633237715
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Total Beneficiary Cost (TBC)",0.0677159968525605
"Section III CY 2019 Formulary Submission Window","Section B.  Calculation of Fee for Service Cost",0.0675048745863757
"Section E.  Clinical Trials","Section I Validation Audits",0.0674421318309375
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0673991964655142
"Section B.  FFS Growth Percentage","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0673525574080539
"Section II Employer Group Waiver Plans","Section I Innovations in Health Plan Design",0.0673342579495843
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0672849707573528
"Section I Enforcement Actions for Provider Directories","Section C.  IME Phase Out",0.0672642358379077
"Section II Transparency   Timeliness with Prior Authorization Processes","Section B.  Calculation of Fee for Service Cost",0.0671944899400913
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0671893184546808
"Section III Specialty Tiers","Section I Plan Corrections",0.06711279484784
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0670678282146612
"Section I Plan Corrections","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0670277135347776
"Section II Maximum Out of Pocket (MOOP) Limits","Section L.  Normalization Factors",0.0669921436685895
"Section M.  Medical Loss Ratio Credibility Adjustment","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0669540654814224
"Section B.  FFS Growth Percentage","Section II Plans with Low Enrollment",0.0669447203356231
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section C.  IME Phase Out",0.0668134015510461
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0667203536321262
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III CY 2019 Formulary Submission Window",0.0666557812133879
"Section III Benefit Review","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0666304821559047
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III CY 2019 Formulary Submission Window",0.066553154853502
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Innovations in Health Plan Design",0.0665083387487046
"Section A.  MA Benchmark  Quality Bonus Payments and Rebate","Section I Validation Audits",0.0664718603162719
"Section II Maximum Out of Pocket (MOOP) Limits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0664500397850068
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Improving Access to Part D Vaccines",0.0664001255760362
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Incomplete and Inaccurate Bid Submissions",0.0663822609598142
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0663753864018586
"Section C.  IME Phase Out","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0663428121139077
"Section M.  Medical Loss Ratio Credibility Adjustment","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0663287092856608
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Plan Corrections",0.0662809965686041
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0662107198771951
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.066164344178413
"Section II Health Related Supplemental Benefits","Section I Validation Audits",0.0661365184801329
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0661303225344891
"Section O.  Quality Payment Program","Section III CY 2019 Formulary Submission Window",0.0660663821301959
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section K.  Medicare Advantage Coding Pattern Adjustment",0.066019603397145
"Section II Part C Optional Supplemental Benefits","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0660021244347488
"Section II Overview of CY 2019 Benefits and Bid Review","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0659923964978127
"Section D.  Retiree Drug Subsidy Amounts","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0659858805321876
"Section C.  IME Phase Out","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0659530426316799
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0659404167826806
"Section I Innovations in Health Plan Design","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.06591744870555
"Section II Cost Plan Transition to MA under MACRA","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0659086835171001
"Section A.  MA Growth Percentage","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0658486397766393
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section D.  ESRD Rates",0.0658187964821262
"Section A.  Update of the RxHCC Model","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0657604494033883
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0657574226841081
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0657005718239165
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0655908771768411
"Section II Transparency   Timeliness with Prior Authorization Processes","Section A.  Update of the RxHCC Model",0.0655213402716516
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section E.  Clinical Trials",0.0654127280623675
"Section B.  FFS Growth Percentage","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0653723672718738
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section D.  Retiree Drug Subsidy Amounts",0.0653720450460614
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section C.  IME Phase Out",0.065314081844575
"Section I Plan Corrections","Section I Innovations in Health Plan Design",0.0652485154987818
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Plan Corrections",0.0652111316751378
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section A.  Update of the RxHCC Model",0.0651582922032364
"Section II Employer Group Waiver Plans","Section D.  ESRD Rates",0.0651564636456624
"Section D.  ESRD Rates","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0651435586922989
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0650765853726788
"Section B.  FFS Growth Percentage","Section II Maximum Out of Pocket (MOOP) Limits",0.0649884522457089
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0648967664563956
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section B.  FFS Growth Percentage",0.0648762494061238
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0648561681487112
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0647962945022615
"Section III Benefit Review","Section I Plan Corrections",0.0646874368287058
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0646473067941527
"Section III Specialty Tiers","Section II Part C Optional Supplemental Benefits",0.0646212309557041
"Section C.  IME Phase Out","Section A.  Update of the RxHCC Model",0.0645905359615353
"Section G.  MA Employer Group Waiver Plans","Section I Validation Audits",0.0645207315609555
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Tier Composition",0.06447234211925
"Section I Annual Calendar","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0644306685655726
"Section IV   Medicare Medicaid Plans","Section L.  Normalization Factors",0.0644107224556246
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0642378067664904
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Part C Optional Supplemental Benefits",0.0641430016952115
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Plans with Low Enrollment",0.0641414518943077
"Section C.  Part D Risk Sharing","Section II Part C Cost Sharing Standards",0.064122328714418
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Tier Composition",0.0640991197263158
"Section III Specialty Tiers","Section II Maximum Out of Pocket (MOOP) Limits",0.0640745293676358
"Section III Specialty Tiers","Section II Overview of CY 2019 Benefits and Bid Review",0.06407385564709
"Section III Coordination of Benefits (COB) User Fee","Section G.  MA Employer Group Waiver Plans",0.0640700017126246
"Section III Specialty Tiers","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0640466999537122
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0640018605431473
"Section II Cost Plan Transition to MA under MACRA","Section I Innovations in Health Plan Design",0.0639893075690503
"Section III Benefit Review","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.063968818069666
"Section A.  MA Growth Percentage","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0639509462505696
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.063943915763411
"Section B.  FFS Growth Percentage","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0639241332284075
"Section I Annual Calendar","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0639217457522841
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Cost Plan Competition Requirements",0.063849059513236
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section G.  MA Employer Group Waiver Plans",0.0638460050377804
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section G.  MA Employer Group Waiver Plans",0.0635776920815986
"Section III Expanding the Part D OTC Program","Section G.  MA Employer Group Waiver Plans",0.0634832677492627
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Tier Composition",0.0634660507791506
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0634555800876306
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0634159641854901
"Section D.  Retiree Drug Subsidy Amounts","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0633535032032918
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0633352360579642
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0633300496381124
"Section II Part C Optional Supplemental Benefits","Section E.  Clinical Trials",0.0633188038198204
"Section III Coordination of Benefits (COB) User Fee","Section I Innovations in Health Plan Design",0.0632881911690239
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Health Related Supplemental Benefits",0.0632257287228314
"Section I Annual Calendar","Section L.  Normalization Factors",0.063184530604596
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0631474001961172
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section II Total Beneficiary Cost (TBC)",0.0631438594951988
"Section A.  MA Growth Percentage","Section III Specialty Tiers",0.0631174757774868
"Section III Benefit Review","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0630959848525894
"Section II Transparency   Timeliness with Prior Authorization Processes","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0630894489024944
"Section B.  FFS Growth Percentage","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0630543678751857
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0630012909339085
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0629727177321939
"Section II Part C Optional Supplemental Benefits","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0629262697752177
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0629226432556293
"Section III Benefit Review","Section D.  ESRD Rates",0.0629069664835366
"Section III Tier Composition","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0628791861796839
"Section III Coordination of Benefits (COB) User Fee","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0628760889512449
"Section II Outpatient Observation Services","Section A.  Update of the RxHCC Model",0.0628675440273104
"Section E.  Clinical Trials","Section III CY 2019 Formulary Submission Window",0.0628450415846924
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Innovations in Health Plan Design",0.0627068266367417
"Section II Cost Plan Transition to MA under MACRA","Section D.  ESRD Rates",0.0626568383896357
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0626526240091757
"Section O.  Quality Payment Program","Section C.  Part D Risk Sharing",0.0626354449899072
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section B.  FFS Growth Percentage",0.0625687779140675
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0625632069356474
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0625149816039365
"Section II Cost Plan Transition to MA under MACRA","Section L.  Normalization Factors",0.0624303169905962
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0623310073810978
"Section III Coordination of Benefits (COB) User Fee","Section I Validation Audits",0.0621531440017028
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Part C Cost Sharing Standards",0.0621151552903512
"Section I Innovations in Health Plan Design","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0620723688825499
"Section III Specialty Tiers","Section E.  Clinical Trials",0.0620070114307023
"Section I Enforcement Actions for Provider Directories","Section II Part C Cost Sharing Standards",0.0619696266290403
"Section A.  MA Growth Percentage","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0619117905554662
"Section C.  Part D Risk Sharing","Section I Incomplete and Inaccurate Bid Submissions",0.0619095164387073
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Plan Corrections",0.0617963174545592
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III CY 2019 Formulary Submission Window",0.0616550174891818
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0614568204725114
"Section B.  FFS Growth Percentage","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0612979330259797
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section I Validation Audits",0.0612493826221415
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section IV   Medicare Medicaid Plans",0.0612308159876999
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section II Total Beneficiary Cost (TBC)",0.061225524379635
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0611970234491674
"Section III Benefit Review","Section O.  Quality Payment Program",0.061000900772547
"Section II Employer Group Waiver Plans","Section A.  Update of the RxHCC Model",0.0609946345667073
"Section III Specialty Tiers","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0609488552651974
"Section III Improving Access to Part D Vaccines","Section O.  Quality Payment Program",0.0608885449269623
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0607982101270404
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section E.  Clinical Trials",0.0607868805799916
"Section II Part C Optional Supplemental Benefits","Section B.  FFS Growth Percentage",0.0607716256921882
"Section II Part C Optional Supplemental Benefits","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.060696076521777
"Section M.  Medical Loss Ratio Credibility Adjustment","Section B.  Calculation of Fee for Service Cost",0.060627328129825
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0606105056013039
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section B.  Calculation of Fee for Service Cost",0.0605488898422438
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0605365319246039
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Health Related Supplemental Benefits",0.060435911478864
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Transparency   Timeliness with Prior Authorization Processes",0.0603717707604036
"Section C.  Part D Risk Sharing","Section III CY 2019 Formulary Submission Window",0.0602922329938368
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section B.  Calculation of Fee for Service Cost",0.0602273254651376
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.060153923625857
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0600797505592024
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section G.  MA Employer Group Waiver Plans",0.0600246872281263
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section G.  MA Employer Group Waiver Plans",0.0600217017990691
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section II Part C Cost Sharing Standards",0.0600067098025712
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0599264844714696
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0599147420677836
"Section II Transparency   Timeliness with Prior Authorization Processes","Section III Tier Composition",0.0597604482189041
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Tiered Cost Sharing of Medical Benefits",0.0595608683932031
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section E.  Clinical Trials",0.0595551640912367
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section B.  FFS Growth Percentage",0.0594365630335599
"Section III Tier Composition","Section G.  MA Employer Group Waiver Plans",0.0593577232562756
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section M.  Medical Loss Ratio Credibility Adjustment",0.059342952555457
"Section M.  Medical Loss Ratio Credibility Adjustment","Section G.  MA Employer Group Waiver Plans",0.059297070625391
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section O.  Quality Payment Program",0.0592958785396636
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0592943605697811
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section A.  Update of the RxHCC Model",0.0592335924060726
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Health Related Supplemental Benefits",0.0591836866158419
"Section II Plans with Low Enrollment","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0591706993451687
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section II Health Related Supplemental Benefits",0.0591480814982086
"Section I Enforcement Actions for Provider Directories","Section II Health Related Supplemental Benefits",0.059128391972861
"Section II Part C Optional Supplemental Benefits","Section C.  IME Phase Out",0.0591228025239422
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section C.  Part D Risk Sharing",0.0590933713660145
"Section D.  Retiree Drug Subsidy Amounts","Section L.  Normalization Factors",0.0589416629857625
"Section C.  IME Phase Out","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0589101351623579
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section I Incomplete and Inaccurate Bid Submissions",0.0589070189763325
"Section D.  ESRD Rates","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0588350943509709
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0587774822289418
"Section M.  Medical Loss Ratio Credibility Adjustment","Section D.  ESRD Rates",0.0586485991645833
"Section II Plans with Low Enrollment","Section III Tier Composition",0.0586079609419424
"Section C.  IME Phase Out","Section M.  Medical Loss Ratio Credibility Adjustment",0.0585469495815989
"Section C.  Part D Risk Sharing","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0585302845992388
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0584795879043783
"Section O.  Quality Payment Program","Section II Maximum Out of Pocket (MOOP) Limits",0.0584533851339373
"Section A.  MA Growth Percentage","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0584476005012806
"Section III Improving Access to Part D Vaccines","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0584251499849067
"Section II Transparency   Timeliness with Prior Authorization Processes","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0583970497721441
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Plan Corrections",0.0583335131089836
"Section II Outpatient Observation Services","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0582959282540398
"Section II Plans with Low Enrollment","Section L.  Normalization Factors",0.0582740356577739
"Section I Enforcement Actions for Provider Directories","Section O.  Quality Payment Program",0.0582649614845908
"Section II Medicare Advantage (MA) Uniformity Flexibility","Section M.  Medical Loss Ratio Credibility Adjustment",0.0582610024598973
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Tier Composition",0.0582591393832536
"Section II Health Related Supplemental Benefits","Section L.  Normalization Factors",0.0582174552934341
"Section III Specialty Tiers","Section B.  FFS Growth Percentage",0.0581930339348714
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0581707067179013
"Section I Enforcement Actions for Provider Directories","Section M.  Medical Loss Ratio Credibility Adjustment",0.0580590790088951
"Section III Specialty Tiers","Section II Plans with Low Enrollment",0.0580028883579651
"Section D.  Retiree Drug Subsidy Amounts","Section C.  Part D Risk Sharing",0.0579434035635544
"Section A.  MA Growth Percentage","Section M.  Medical Loss Ratio Credibility Adjustment",0.0578549692320765
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Innovations in Health Plan Design",0.0578183362192733
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Cost Plan Transition to MA under MACRA",0.0578103320195784
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section O.  Quality Payment Program",0.0577889659959321
"Section II Transparency   Timeliness with Prior Authorization Processes","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0577602282364701
"Section B.  Calculation of Fee for Service Cost","Section I Validation Audits",0.0577327662309559
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0576618291486194
"Section A.  Update of the RxHCC Model","Section I Validation Audits",0.0576400445730694
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section O.  Quality Payment Program",0.057590455571432
"Section III Coordination of Benefits (COB) User Fee","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0574924020695778
"Section C.  IME Phase Out","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0573963858400796
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section D.  ESRD Rates",0.0573513133103277
"Section II Employer Group Waiver Plans","Section I Enforcement Actions for Provider Directories",0.0573346917005784
"Section D.  ESRD Rates","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.057325912361212
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Plan Corrections",0.0573119669300871
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0572525013571611
"Section III Coordination of Benefits (COB) User Fee","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0571819853484867
"Section I Annual Calendar","Section B.  FFS Growth Percentage",0.0571469592400566
"Section II Employer Group Waiver Plans","Section III Expanding the Part D OTC Program",0.0571437901103118
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0570357235710973
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section C.  IME Phase Out",0.0569648777391437
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III CY 2019 Formulary Submission Window",0.0569195640217678
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III CY 2019 Formulary Submission Window",0.0568634416100243
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III CY 2019 Formulary Submission Window",0.0568545604619928
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0568542206657585
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0568374355118569
"Section II Employer Group Waiver Plans","Section III Tier Composition",0.0567578969012724
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0567286057078487
"Section II Part C Optional Supplemental Benefits","Section I Innovations in Health Plan Design",0.0567046394399994
"Section II Outpatient Observation Services","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0566004154066472
"Section III Specialty Tiers","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0564975615775078
"Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0564562507917386
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section B.  FFS Growth Percentage",0.0564535751369378
"Section II Part C Optional Supplemental Benefits","Section D.  Retiree Drug Subsidy Amounts",0.056439922412301
"Section II Tiered Cost Sharing of Medical Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0564170941159738
"Section II Outpatient Observation Services","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0564159459074973
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Validation Audits",0.0563663715348175
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section III CY 2019 Formulary Submission Window",0.0563425657018532
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0562414188951614
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section D.  ESRD Rates",0.0562206988560482
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section B.  FFS Growth Percentage",0.0562139924165952
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section O.  Quality Payment Program",0.056165595630173
"Section II Maximum Out of Pocket (MOOP) Limits","Section III CY 2019 Formulary Submission Window",0.0561621514922374
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.056139489231213
"Section II Outpatient Observation Services","Section O.  Quality Payment Program",0.0561041564916775
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0560454171799142
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0559947367421077
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section L.  Normalization Factors",0.0559708152244684
"Section III Expanding the Part D OTC Program","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0558445379151741
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Innovations in Health Plan Design",0.0557732039068357
"Section A.  MA Growth Percentage","Section II Part C Cost Sharing Standards",0.0557624670931838
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0557147414855092
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0557105704353803
"Section M.  Medical Loss Ratio Credibility Adjustment","Section A.  Update of the RxHCC Model",0.0556248566664254
"Section A.  MA Growth Percentage","Section II Transparency   Timeliness with Prior Authorization Processes",0.0555281815427798
"Section II Part C Optional Supplemental Benefits","Section D.  ESRD Rates",0.0555238611622835
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0554136834194672
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Incomplete and Inaccurate Bid Submissions",0.0553975209339825
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Health Related Supplemental Benefits",0.0553792937129733
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section M.  Medical Loss Ratio Credibility Adjustment",0.055374886603749
"Section III Specialty Tiers","Section II Health Related Supplemental Benefits",0.055296100287879
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0552894541591443
"Section III Specialty Tiers","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0552093344791973
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0551963746141895
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section C.  Part D Risk Sharing",0.0551894085352059
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Validation Audits",0.0551705844707285
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Part C Cost Sharing Standards",0.055092473199365
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0550347744020779
"Section II Maximum Out of Pocket (MOOP) Limits","Section C.  Part D Risk Sharing",0.0550268554475202
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Validation Audits",0.0550108104601639
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section L.  Normalization Factors",0.0549969891990154
"Section D.  ESRD Rates","Section E.  Clinical Trials",0.0549669631876217
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Enforcement Actions for Provider Directories",0.0549210185803678
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section IV   Medicare Medicaid Plans",0.0548798158345353
"Section B.  FFS Growth Percentage","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0548704366277497
"Section III Benefit Review","Section I Validation Audits",0.0547658721424428
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Annual Calendar",0.0547573534099861
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section G.  MA Employer Group Waiver Plans",0.0547555564208285
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Expanding the Part D OTC Program",0.0547448901451359
"Section I Enforcement Actions for Provider Directories","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0547109325354024
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section L.  Normalization Factors",0.0546672069259569
"Section C.  IME Phase Out","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0546652611718672
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Plans with Low Enrollment",0.0545300693217568
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0545230209465764
"Section II Cost Plan Transition to MA under MACRA","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0544989925651566
"Section III Benefit Review","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0544835765283196
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Tier Composition",0.0544590444509285
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Tiered Cost Sharing of Medical Benefits",0.0544516365155172
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Plans with Low Enrollment",0.0543865442580273
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0543780875742017
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0543456770176836
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Part C Cost Sharing Standards",0.0543348102875866
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0542866952403883
"Section III Coordination of Benefits (COB) User Fee","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0542626417337613
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section M.  Medical Loss Ratio Credibility Adjustment",0.054168547551667
"Section D.  Retiree Drug Subsidy Amounts","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0541174208216499
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0540727121284582
"Section C.  IME Phase Out","Section C.  Part D Risk Sharing",0.0540276692517997
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0539827282899788
"Section B.  FFS Growth Percentage","Section I Validation Audits",0.0539723244578134
"Section I Enforcement Actions for Provider Directories","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0539641773995955
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section C.  IME Phase Out",0.0539163866017192
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Overview of CY 2019 Benefits and Bid Review",0.0539034074345792
"Section C.  IME Phase Out","Section I Validation Audits",0.0538933218631865
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Maximum Out of Pocket (MOOP) Limits",0.0538243457259535
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0537518379085939
"Section I Annual Calendar","Section D.  ESRD Rates",0.0537280305417228
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section D.  ESRD Rates",0.0535547771509142
"Section II Part C Optional Supplemental Benefits","Section I.  ESRD Risk Adjustment Model for CY 2019",0.05354204303284
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section L.  Normalization Factors",0.0535220852414899
"Section III Benefit Review","Section II Plans with Low Enrollment",0.0534760207867655
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Part C Cost Sharing Standards",0.0533388721355273
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B.  FFS Growth Percentage",0.0533191167974728
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0531934467779574
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section E.  Clinical Trials",0.0531601150861986
"Section III Benefit Review","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.053157743395375
"Section M.  Medical Loss Ratio Credibility Adjustment","Section L.  Normalization Factors",0.0531058430479237
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section G.  MA Employer Group Waiver Plans",0.0530253789704138
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Overview of CY 2019 Benefits and Bid Review",0.0530146039351004
"Section B.  FFS Growth Percentage","Section C.  Part D Risk Sharing",0.0530101079334016
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0528285901166885
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section C.  IME Phase Out",0.0528270543795374
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Validation Audits",0.0528044556433551
"Section I Enforcement Actions for Provider Directories","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.052688661479778
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Tier Composition",0.0526860839526074
"Section II Tiered Cost Sharing of Medical Benefits","Section I Plan Corrections",0.0525277485464876
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Health Related Supplemental Benefits",0.0524742714522103
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section D.  ESRD Rates",0.0524020065322071
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Incomplete and Inaccurate Bid Submissions",0.0522764366551316
"Section II Cost Plan Competition Requirements","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0522190352189962
"Section A.  MA Growth Percentage","Section II Cost Plan Transition to MA under MACRA",0.0521640530957301
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0521546592591014
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section L.  Normalization Factors",0.0521524386782973
"Section III Improving Access to Part D Vaccines","Section L.  Normalization Factors",0.0521367442652959
"Section II Employer Group Waiver Plans","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0521199329955081
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0521120092930288
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0520824275010598
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Part C Optional Supplemental Benefits",0.0520406543203939
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.051969611964375
"Section C.  IME Phase Out","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0519562898945257
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Incomplete and Inaccurate Bid Submissions",0.051817212732754
"Section D.  Retiree Drug Subsidy Amounts","Section C.  IME Phase Out",0.0518011886782478
"Section II Transparency   Timeliness with Prior Authorization Processes","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0517660746347451
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Expanding the Part D OTC Program",0.0517577124737807
"Section III Coordination of Benefits (COB) User Fee","Section II Maximum Out of Pocket (MOOP) Limits",0.0516455880557603
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section M.  Medical Loss Ratio Credibility Adjustment",0.0516372986557388
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Tiered Cost Sharing of Medical Benefits",0.0516232611481304
"Section II Outpatient Observation Services","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0515873015873016
"Section C.  IME Phase Out","Section III Improving Access to Part D Vaccines",0.0515482315681283
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Innovations in Health Plan Design",0.0515361734927048
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Overview of CY 2019 Benefits and Bid Review",0.051528254085829
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section O.  Quality Payment Program",0.0515243485230103
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Plan Corrections",0.0515188912704368
"Section III Benefit Review","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0515093957343714
"Section III Benefit Review","Section L.  Normalization Factors",0.0514648190423847
"Section C.  IME Phase Out","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0514137316300701
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section L.  Normalization Factors",0.0513709789633298
"Section II Cost Plan Competition Requirements","Section C.  Part D Risk Sharing",0.051318848442732
"Section A.  MA Growth Percentage","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0511937752153777
"Section B.  FFS Growth Percentage","Section I Innovations in Health Plan Design",0.0510639453689524
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section E.  Clinical Trials",0.051031593333468
"Section III CY 2019 Formulary Submission Window","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0510126166771256
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section L.  Normalization Factors",0.051008059588429
"Section C.  IME Phase Out","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0509267710390978
"Section D.  ESRD Rates","Section III Expanding the Part D OTC Program",0.0509026561390469
"Section III Benefit Review","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0509004913688512
"Section C.  Part D Risk Sharing","Section E.  Clinical Trials",0.0508206489037231
"Section B.  FFS Growth Percentage","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0508046087762734
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0506839196562071
"Section D.  Retiree Drug Subsidy Amounts","Section II Plans with Low Enrollment",0.0506594886881204
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0505957206312838
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section C.  Part D Risk Sharing",0.0505771491149261
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Part C Cost Sharing Standards",0.0505634367774847
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0505443983115551
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section C.  Part D Risk Sharing",0.0505169938451045
"Section B.  FFS Growth Percentage","Section III CY 2019 Formulary Submission Window",0.0504880948925904
"Section III Coordination of Benefits (COB) User Fee","Section D.  ESRD Rates",0.0502462066651272
"Section B.  FFS Growth Percentage","Section III Improving Access to Part D Vaccines",0.0501661700563977
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.05014122105639
"Section II Cost Plan Competition Requirements","Section B.  FFS Growth Percentage",0.0500840062520871
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section O.  Quality Payment Program",0.050075345385012
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0500089309637222
"Section III Coordination of Benefits (COB) User Fee","Section B.  FFS Growth Percentage",0.0499956005807148
"Section III Specialty Tiers","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0499735923642106
"Section I Innovations in Health Plan Design","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.049929881052656
"Section II Outpatient Observation Services","Section III CY 2019 Formulary Submission Window",0.0497942457982181
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0497358454178628
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section D.  ESRD Rates",0.0497162763505752
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0496634291580632
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0496450974413908
"Section II Employer Group Waiver Plans","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0496291666985465
"Section B.  FFS Growth Percentage","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0495973773682879
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section B.  Calculation of Fee for Service Cost",0.0494310277454831
"Section III Expanding the Part D OTC Program","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0494304640486468
"Section B.  FFS Growth Percentage","Section I Plan Corrections",0.0492921079442575
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Overview of CY 2019 Benefits and Bid Review",0.0492835554833718
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0492792017739238
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section I Enforcement Actions for Provider Directories",0.049177948987712
"Section II Cost Plan Competition Requirements","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0491671943732305
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0489809990578335
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Validation Audits",0.0489206096492895
"Section B.  FFS Growth Percentage","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0488886436542086
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.04887653253243
"Section A.  MA Growth Percentage","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0488184715508999
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0488150962995639
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Validation Audits",0.0487874920973738
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section C.  Part D Risk Sharing",0.0487660312980539
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0487546438360151
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.048692113492145
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0486621245734541
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section E.  Clinical Trials",0.0486498498065911
"Section B.  FFS Growth Percentage","Section II Health Related Supplemental Benefits",0.0486252562567254
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0485631746171775
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III CY 2019 Formulary Submission Window",0.0485604790217072
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section III Improving Access to Part D Vaccines",0.0485468685048495
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section O.  Quality Payment Program",0.0485326215267708
"Section III Expanding the Part D OTC Program","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0485238202874175
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Coordination of Benefits (COB) User Fee",0.0484396309316052
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Health Related Supplemental Benefits",0.0484094783178082
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0483639873855345
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Validation Audits",0.0483357176791279
"Section B.  FFS Growth Percentage","Section E.  Clinical Trials",0.0482925893510306
"Section II Employer Group Waiver Plans","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0482241714524909
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.048196269271188
"Section I Enforcement Actions for Provider Directories","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0481864325616846
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0481001868369446
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Specialty Tiers",0.0480480567140223
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III CY 2019 Formulary Submission Window",0.0480007347988794
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section C.  Part D Risk Sharing",0.0478807370227491
"Section I Enforcement Actions for Provider Directories","Section G.  MA Employer Group Waiver Plans",0.0478635561353339
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0477323910278031
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0477108309952402
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Cost Plan Transition to MA under MACRA",0.0476731294622796
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0476368742748973
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section I Innovations in Health Plan Design",0.0476325466650759
"Section III Benefit Review","Section I Enforcement Actions for Provider Directories",0.0474473465520514
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Innovations in Health Plan Design",0.0474320305091755
"Section A.  Update of the RxHCC Model","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.047422801376202
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0474056503480331
"Section A.  MA Growth Percentage","Section II Maximum Out of Pocket (MOOP) Limits",0.0473970628263126
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section G.  MA Employer Group Waiver Plans",0.047309161456091
"Section I Incomplete and Inaccurate Bid Submissions","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0472846599703116
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.0472223752579456
"Section III Tier Composition","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0470251145533206
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section D.  ESRD Rates",0.0468880844384963
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0468143730591242
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0468130772563462
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0467599740894804
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section C.  Part D Risk Sharing",0.0467207694962052
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0467133970294902
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0467015158568474
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E.  Clinical Trials",0.0466953346305887
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0466865991830087
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0466698336226354
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section L.  Normalization Factors",0.0465269499579852
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section E.  Clinical Trials",0.0465022157794219
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0464473018656992
"Section II Employer Group Waiver Plans","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.046243547127091
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section D.  ESRD Rates",0.046203894570624
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section G.  MA Employer Group Waiver Plans",0.0460648197948198
"Section III Coordination of Benefits (COB) User Fee","Section I Enforcement Actions for Provider Directories",0.0459829252749634
"Section III Benefit Review","Section I Innovations in Health Plan Design",0.045889110658816
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0458703700204468
"Section C.  IME Phase Out","Section I Incomplete and Inaccurate Bid Submissions",0.0457869634812584
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.045786854649563
"Section I Plan Corrections","Section B.  Calculation of Fee for Service Cost",0.0457527601932835
"Section I Plan Corrections","Section C.  Part D Risk Sharing",0.0456971945450776
"Section III Benefit Review","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0455971285656443
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B.  FFS Growth Percentage",0.0455824690161612
"Section II Part C Optional Supplemental Benefits","Section L.  Normalization Factors",0.0455602225672318
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0455258432511495
"Section A.  MA Growth Percentage","Section E.  Clinical Trials",0.0454374047804285
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0454353913744507
"Section II Employer Group Waiver Plans","Section A.  MA Growth Percentage",0.0452042335747207
"Section II Outpatient Observation Services","Section II Plans with Low Enrollment",0.0451954864938855
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Maximum Out of Pocket (MOOP) Limits",0.0451817952422109
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Validation Audits",0.0451626317290307
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0451210728113809
"Section III Specialty Tiers","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0450738091338614
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0450490140629009
"Section A.  MA Growth Percentage","Section I Annual Calendar",0.0449875738988287
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0448105390660199
"Section III Specialty Tiers","Section O.  Quality Payment Program",0.044758518622735
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Plan Corrections",0.0447397622310595
"Section III Benefit Review","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0445966815498621
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Validation Audits",0.0445510704196491
"Section M.  Medical Loss Ratio Credibility Adjustment","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0445465374458908
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0445258263870739
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section L.  Normalization Factors",0.0445251392189648
"Section III Specialty Tiers","Section C.  IME Phase Out",0.0444825635066892
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0443993979482457
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0443921604429005
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0443384812106425
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section L.  Normalization Factors",0.0443133984961819
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section C.  Part D Risk Sharing",0.0442970232504606
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0442859475176847
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Improving Access to Part D Vaccines",0.0441222195052736
"Section II Outpatient Observation Services","Section G.  MA Employer Group Waiver Plans",0.0439668099541847
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0437399940280593
"Section II Part C Optional Supplemental Benefits","Section I Validation Audits",0.0437358316403058
"Section D.  ESRD Rates","Section I Incomplete and Inaccurate Bid Submissions",0.043716468825806
"Section C.  Part D Risk Sharing","Section IV   Medicare Medicaid Plans",0.0436526218624149
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0436423311412643
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III Improving Access to Part D Vaccines",0.0436357937907728
"Section III Tier Composition","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0436224671372482
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section M.  Medical Loss Ratio Credibility Adjustment",0.0435728448426737
"Section A.  MA Growth Percentage","Section II Plans with Low Enrollment",0.0435658512214018
"Section III Benefit Review","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0435340743949286
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section G.  MA Employer Group Waiver Plans",0.0435102250436481
"Section II Plans with Low Enrollment","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0434303989776348
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0433789154984764
"Section I Plan Corrections","Section E.  Clinical Trials",0.0433724185523674
"Section III Specialty Tiers","Section G.  MA Employer Group Waiver Plans",0.0432857232131984
"Section D.  ESRD Rates","Section III CY 2019 Formulary Submission Window",0.0432403010808046
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section D.  Retiree Drug Subsidy Amounts",0.0431833517087531
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0431541814299428
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0430954912887241
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section A.  Update of the RxHCC Model",0.0430513892023534
"Section A.  MA Growth Percentage","Section I Plan Corrections",0.0429616051855389
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Plan Corrections",0.0429057746159016
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0428882351475461
"Section III Specialty Tiers","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0428627592248325
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0427905125346892
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Validation Audits",0.042777375418286
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Tiered Cost Sharing of Medical Benefits",0.0427533599145306
"Section I Enforcement Actions for Provider Directories","Section III CY 2019 Formulary Submission Window",0.0427085960576363
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Tiered Cost Sharing of Medical Benefits",0.04262193596921
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Health Related Supplemental Benefits",0.0426049471088959
"Section D.  Retiree Drug Subsidy Amounts","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0425764503482794
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0425407057757388
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0425221896751149
"Section III Specialty Tiers","Section D.  ESRD Rates",0.0422389717881748
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section III Tier Composition",0.0421921171792303
"Section A.  MA Growth Percentage","Section G.  MA Employer Group Waiver Plans",0.0420911935657839
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0420579115569033
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Improving Access to Part D Vaccines",0.0419362307003568
"Section III Expanding the Part D OTC Program","Section L.  Normalization Factors",0.0419264961331482
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Validation Audits",0.0418759484971254
"Section III Coordination of Benefits (COB) User Fee","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0418006430868167
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0417381871380055
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Total Beneficiary Cost (TBC)",0.0417060202250465
"Section A.  MA Growth Percentage","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0416125189288239
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0414902976072764
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section O.  Quality Payment Program",0.0414830036070667
"Section III Specialty Tiers","Section I Innovations in Health Plan Design",0.0414781074337831
"Section III CY 2019 Formulary Submission Window","Section L.  Normalization Factors",0.0414094934607513
"Section II Outpatient Observation Services","Section I Validation Audits",0.0413616088066882
"Section III Tier Composition","Section A.  MA Benchmark  Quality Bonus Payments and Rebate",0.0413137476250448
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0412432018762087
"Section II Tiered Cost Sharing of Medical Benefits","Section C.  Part D Risk Sharing",0.0411468958000008
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Validation Audits",0.041107165520072
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Plan Corrections",0.0410618004173382
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Plan Corrections",0.041019400171544
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.040988030775753
"Section II Part C Optional Supplemental Benefits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0409548393737383
"Section I.  ESRD Risk Adjustment Model for CY 2019","Section I Validation Audits",0.0409227920381463
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Enforcement Actions for Provider Directories",0.040745325895869
"Section II Tiered Cost Sharing of Medical Benefits","Section I Validation Audits",0.0406751530708549
"Section III Coordination of Benefits (COB) User Fee","Section II Plans with Low Enrollment",0.0406631079171502
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0405925072858483
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section D.  ESRD Rates",0.0405687814627413
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Innovations in Health Plan Design",0.0405544672556712
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0405272271032338
"Section II Outpatient Observation Services","Section III Coordination of Benefits (COB) User Fee",0.0405034269374102
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0404722329258176
"Section II Transparency   Timeliness with Prior Authorization Processes","Section D.  ESRD Rates",0.040458361016749
"Section A.  MA Growth Percentage","Section II Part C Optional Supplemental Benefits",0.0404473957139505
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Plans with Low Enrollment",0.040426513024053
"Section III Specialty Tiers","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0404226041727222
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0403700731509542
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section III Tier Composition",0.0403354223736612
"Section I Plan Corrections","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0403080124409548
"Section II Outpatient Observation Services","Section L.  Normalization Factors",0.040249762216646
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0401888092876402
"Section I Plan Corrections","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0401885631154645
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section M.  Medical Loss Ratio Credibility Adjustment",0.0401318995492914
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0400732199445326
"Section D.  ESRD Rates","Section I Validation Audits",0.0400713050256903
"Section II Cost Plan Competition Requirements","Section III CY 2019 Formulary Submission Window",0.0400093142312066
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0399597408616011
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section M.  Medical Loss Ratio Credibility Adjustment",0.0399443662822611
"Section III Coordination of Benefits (COB) User Fee","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0399406324310969
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0398706303365981
"Section III Coordination of Benefits (COB) User Fee","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0398430510420219
"Section D.  Retiree Drug Subsidy Amounts","Section D.  ESRD Rates",0.0397291435187886
"Section I Enforcement Actions for Provider Directories","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0397283481307989
"Section II Tiered Cost Sharing of Medical Benefits","Section L.  Normalization Factors",0.0396224225892559
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Cost Plan Competition Requirements",0.0394847942899811
"Section III Specialty Tiers","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0394646663074118
"Section I Annual Calendar","Section C.  IME Phase Out",0.0394555654430082
"Section II Health Related Supplemental Benefits","Section C.  Part D Risk Sharing",0.0394441047803345
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Maximum Out of Pocket (MOOP) Limits",0.0394286280234454
"Section II Plans with Low Enrollment","Section III CY 2019 Formulary Submission Window",0.0393833153603151
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Health Related Supplemental Benefits",0.0393493217556103
"Section III Tier Composition","Section O.  Quality Payment Program",0.0393264600304689
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.039294849640811
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section O.  Quality Payment Program",0.0392505537754844
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Tiered Cost Sharing of Medical Benefits",0.039238696059997
"Section II Part C Optional Supplemental Benefits","Section II Outpatient Observation Services",0.0391630224993979
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0390881552497052
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0390608113112418
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0389844687946679
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0389305527565496
"Section II Transparency   Timeliness with Prior Authorization Processes","Section L.  Normalization Factors",0.0387913683707524
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section L.  Normalization Factors",0.0387436838187746
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section L.  Normalization Factors",0.0387011102581539
"Section I Enforcement Actions for Provider Directories","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0385574245399274
"Section D.  Retiree Drug Subsidy Amounts","Section G.  MA Employer Group Waiver Plans",0.0384806755966908
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section C.  Part D Risk Sharing",0.0384091043816745
"Section II Cost Plan Transition to MA under MACRA","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0383360016960559
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Expanding the Part D OTC Program",0.0383167074893086
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0383158954756632
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Part C Cost Sharing Standards",0.0382868758376451
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Health Related Supplemental Benefits",0.0382261594660401
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0382004146181828
"Section II Employer Group Waiver Plans","Section L.  Normalization Factors",0.0381887678976401
"Section III Coordination of Benefits (COB) User Fee","Section M.  Medical Loss Ratio Credibility Adjustment",0.0381177587189444
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0380745739331167
"Section A.  MA Growth Percentage","Section K.  Medicare Advantage Coding Pattern Adjustment",0.038069349381344
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Tier Composition",0.0380579539627341
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0379389862629642
"Section II Outpatient Observation Services","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0379103494595911
"Section I Enforcement Actions for Provider Directories","Section II Cost Plan Transition to MA under MACRA",0.0378069506906769
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Cost Plan Competition Requirements",0.0376671881254118
"Section II Part C Optional Supplemental Benefits","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0376561839951674
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0376428197554825
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Coordination of Benefits (COB) User Fee",0.0376229983413609
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section D.  ESRD Rates",0.0376219402112601
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section I Validation Audits",0.0376190679592529
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0376022231091473
"Section II Cost Plan Competition Requirements","Section I Plan Corrections",0.0373096236642261
"Section III Benefit Review","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.037205841478034
"Section I Plan Corrections","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0371189456611218
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Specialty Tiers",0.0370822800370008
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Improving Drug Utilization Review Controls in Medicare Part D",0.0370395298284843
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Plan Corrections",0.0368127886795431
"Section II Transparency   Timeliness with Prior Authorization Processes","Section B.  FFS Growth Percentage",0.0367560009070121
"Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program","Section C.  Part D Risk Sharing",0.0367486543917248
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0367472461012469
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0366418380194548
"Section II Part C Optional Supplemental Benefits","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0366234963698589
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Maximum Out of Pocket (MOOP) Limits",0.0365675998705233
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section G.  MA Employer Group Waiver Plans",0.0365645302313826
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0365421321529538
"Section II Overview of CY 2019 Benefits and Bid Review","Section C.  Part D Risk Sharing",0.0364794737219193
"Section C.  Part D Risk Sharing","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0364181806091974
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0363096621065799
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section L.  Normalization Factors",0.0362800502715238
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0362450517461912
"Section M.  Medical Loss Ratio Credibility Adjustment","Section O.  Quality Payment Program",0.0362242571077921
"Section II Tiered Cost Sharing of Medical Benefits","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0362160202031589
"Section A.  MA Growth Percentage","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0361883529565437
"Section III Coordination of Benefits (COB) User Fee","Section O.  Quality Payment Program",0.0361129036423585
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section C.  Part D Risk Sharing",0.0359950151795426
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Transparency   Timeliness with Prior Authorization Processes",0.0359930899900192
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Part C Cost Sharing Standards",0.0359226885033121
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III CY 2019 Formulary Submission Window",0.0357910849030168
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Coordination of Benefits (COB) User Fee",0.0356656677667594
"Section II Outpatient Observation Services","Section I Enforcement Actions for Provider Directories",0.0356447349458174
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Plan Corrections",0.0356372985893705
"Section A.  MA Growth Percentage","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0356149633756895
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0354774900348534
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0354731754090385
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Expanding the Part D OTC Program",0.03529123141083
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0352408089914234
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0352363581383274
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.035186460478522
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section A.  Update of the RxHCC Model",0.0351441321093707
"Section L.  Normalization Factors","Section I Validation Audits",0.0350860004511783
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0350329236163592
"Section D.  ESRD Rates","Section III Tier Composition",0.0350191580524109
"Section III Specialty Tiers","Section L.  Normalization Factors",0.0349925405798201
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0349477745651314
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0349315744477782
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0349116055302693
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0348737025453078
"Section A.  MA Growth Percentage","Section O.  Quality Payment Program",0.034714272286033
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0346819786772001
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Validation Audits",0.0346139263773942
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Outpatient Observation Services",0.034535269886802
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section L.  Normalization Factors",0.034351890695074
"Section A.  Update of the RxHCC Model","Section I Plan Corrections",0.0341709808275835
"Section D.  Retiree Drug Subsidy Amounts","Section O.  Quality Payment Program",0.0339929648641233
"Section I Enforcement Actions for Provider Directories","Section B.  Calculation of Fee for Service Cost",0.0339565054500958
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Outpatient Observation Services",0.0338984998483035
"Section III Specialty Tiers","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0338821514027671
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Validation Audits",0.0338636663578527
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0338371211410932
"Section II Tiered Cost Sharing of Medical Benefits","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0337935356996952
"Section D.  Retiree Drug Subsidy Amounts","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0337609800121785
"Section A.  MA Growth Percentage","Section III Expanding the Part D OTC Program",0.0337099931231621
"Section I Enforcement Actions for Provider Directories","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0336538651685066
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0336035100699498
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0335593731057589
"Section III Benefit Review","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0335141928621461
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Transparency   Timeliness with Prior Authorization Processes",0.0334599773623254
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0334431793849195
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Health Related Supplemental Benefits",0.0334086698520622
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section E.  Clinical Trials",0.0333687807431179
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0333131496600729
"Section II Maximum Out of Pocket (MOOP) Limits","Section I Validation Audits",0.0332909344147238
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0332779162819861
"Section II Health Related Supplemental Benefits","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0332159967039104
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.033095019828593
"Section A.  MA Growth Percentage","Section I Incomplete and Inaccurate Bid Submissions",0.0330642358660717
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Cost Plan Competition Requirements",0.0330609876522487
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Transparency   Timeliness with Prior Authorization Processes",0.0329741442761214
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0329439174780206
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section I Validation Audits",0.0328804631574418
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Total Beneficiary Cost (TBC)",0.0328711189537798
"Section C.  IME Phase Out","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0328602793927532
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section C.  IME Phase Out",0.0327934957272174
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0327659096918093
"Section III Specialty Tiers","Section II Outpatient Observation Services",0.0327392320367218
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0327326166299405
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Improving Access to Part D Vaccines",0.0325564541760446
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0325424018993567
"Section A.  MA Growth Percentage","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0325300024316178
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0322463224158667
"Section D.  Retiree Drug Subsidy Amounts","Section II Health Related Supplemental Benefits",0.0321969272718848
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III CY 2019 Formulary Submission Window",0.032184989418556
"Section A.  MA Growth Percentage","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.032172911456733
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Advantage (MA) Uniformity Flexibility",0.032153214278577
"Section A.  MA Growth Percentage","Section II Health Related Supplemental Benefits",0.0321384670742767
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Overview of CY 2019 Benefits and Bid Review",0.0320561750033068
"Section I Enforcement Actions for Provider Directories","Section A.  Update of the RxHCC Model",0.03202615215154
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Plan Corrections",0.0319796666392965
"Section A.  MA Growth Percentage","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0319369274626851
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section E.  Clinical Trials",0.0319066571222249
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section M.  Medical Loss Ratio Credibility Adjustment",0.0318689227714156
"Section II Cost Plan Transition to MA under MACRA","Section C.  Part D Risk Sharing",0.0318667356370897
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Part C Cost Sharing Standards",0.0318426126320417
"Section A.  MA Growth Percentage","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0318110185729927
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0317765644315304
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0317413533880143
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Part C Optional Supplemental Benefits",0.0316844452592867
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section B.  FFS Growth Percentage",0.0316751756046499
"Section M.  Medical Loss Ratio Credibility Adjustment","Section E.  Clinical Trials",0.0315643134122782
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Part C Optional Supplemental Benefits",0.0315584628706574
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0315413996291447
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0315253467634964
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.031472534218543
"Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs","Section L.  Normalization Factors",0.0314261270242872
"Section B.  FFS Growth Percentage","Section I Incomplete and Inaccurate Bid Submissions",0.0313759168767202
"Section I Innovations in Health Plan Design","Section C.  Part D Risk Sharing",0.0313466312305142
"Section II Transparency   Timeliness with Prior Authorization Processes","Section C.  Part D Risk Sharing",0.0313124892591883
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0312646055965995
"Section D.  Retiree Drug Subsidy Amounts","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.031176238542953
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0311112529291115
"Section III Specialty Tiers","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0309810343474238
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Improving Access to Part D Vaccines",0.0309437347027769
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section L.  Normalization Factors",0.0309222239443791
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0309221471768711
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.030584293454951
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section O.  Quality Payment Program",0.0305693283524174
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Tier Composition",0.0305597761907471
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section II Plans with Low Enrollment",0.0305488210999544
"Section I Enforcement Actions for Provider Directories","Section III Improving Access to Part D Vaccines",0.0305465289943295
"Section III Coordination of Benefits (COB) User Fee","Section C.  Part D Risk Sharing",0.0305154302312774
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section L.  Normalization Factors",0.030408038515251
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section L.  Normalization Factors",0.0301929967438428
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0300823171623001
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0299644383316996
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Tier Composition",0.0298561044573771
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0297869276797118
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0297840737815611
"Section I Incomplete and Inaccurate Bid Submissions","Section L.  Normalization Factors",0.0297705222548521
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0297559992282338
"Section II Plans with Low Enrollment","Section C.  Part D Risk Sharing",0.029745216400108
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Plan Corrections",0.0297041142729319
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III CY 2019 Formulary Submission Window",0.0295929374689183
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section M.  Medical Loss Ratio Credibility Adjustment",0.0295540231644524
"Section II Outpatient Observation Services","Section M.  Medical Loss Ratio Credibility Adjustment",0.0295478679997154
"Section D.  ESRD Rates","Section II Health Related Supplemental Benefits",0.0295250168483977
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Medicare Advantage (MA) Uniformity Flexibility",0.0294050529573739
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section B.  Encounter Data as a Diagnosis Source for 2019",0.02939524088422
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section B.  FFS Growth Percentage",0.0293894006607749
"Section A.  MA Growth Percentage","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0292822316253448
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0292623320432807
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Plans with Low Enrollment",0.0292296932022088
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Part C Cost Sharing Standards",0.0291209986856645
"Section A.  MA Growth Percentage","Section II Tiered Cost Sharing of Medical Benefits",0.0291111254869791
"Section I Annual Calendar","Section C.  Part D Risk Sharing",0.02909929089384
"Section III Benefit Review","Section A.  MA Growth Percentage",0.0290957186981323
"Section II Employer Group Waiver Plans","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0290895628282447
"Section A.  MA Growth Percentage","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.029087239689152
"Section A.  MA Growth Percentage","Section I Validation Audits",0.0290720306738956
"Section I Enforcement Actions for Provider Directories","Section II Maximum Out of Pocket (MOOP) Limits",0.0290670585156776
"Section II Employer Group Waiver Plans","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0290401159748387
"Section A.  MA Growth Percentage","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0289885517826224
"Section III Specialty Tiers","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.0289083619975164
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0288958878513135
"Section III Low Enrollment Plans (Stand alone PDPs only)","Section C.  Part D Risk Sharing",0.0288714193267144
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.0288652584492478
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0287554061875836
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0286692692523411
"Section III Specialty Tiers","Section I Enforcement Actions for Provider Directories",0.0285910405828248
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Transition to MA under MACRA",0.0284901441149095
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Innovations in Health Plan Design",0.028471991743449
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Health Related Supplemental Benefits",0.0282206160409148
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Annual Calendar",0.0281927930811906
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Improving Access to Part D Vaccines",0.0281864274666508
"Section D.  Retiree Drug Subsidy Amounts","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0281281058336646
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section A.  MA Growth Percentage",0.0281091347570523
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section IV   Medicare Medicaid Plans",0.0280933391029601
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section IV   Medicare Medicaid Plans",0.0280363626844069
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III Tier Composition",0.0280125112556239
"Section B.  FFS Growth Percentage","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0279975363252003
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section D.  Retiree Drug Subsidy Amounts",0.027780402656383
"Section II Outpatient Observation Services","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0277100389131459
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Tiered Cost Sharing of Medical Benefits",0.0275778696808168
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section D.  ESRD Rates",0.0275676024169908
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Incomplete and Inaccurate Bid Submissions",0.0275546202320705
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0274817225574852
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.027416416900227
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0273110722178328
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Health Related Supplemental Benefits",0.0272638510669484
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section M.  Medical Loss Ratio Credibility Adjustment",0.0271027592338671
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0270933305471202
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0270898968825038
"Section II Employer Group Waiver Plans","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0270544885015532
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section II Maximum Out of Pocket (MOOP) Limits",0.0270444526756969
"Section I Annual Calendar","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0269742007800333
"Section I Enforcement Actions for Provider Directories","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0269043039677831
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section C.  Part D Risk Sharing",0.0268778361813219
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Incomplete and Inaccurate Bid Submissions",0.0268309078221644
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.026775777137941
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.026734480022052
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.026713025299917
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Incomplete and Inaccurate Bid Submissions",0.0267034993810787
"Section D.  Retiree Drug Subsidy Amounts","Section I Innovations in Health Plan Design",0.0265663285767919
"Section III Coordination of Benefits (COB) User Fee","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0265138875990055
"Section III Benefit Review","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0264689489140053
"Section I Enforcement Actions for Provider Directories","Section B.  FFS Growth Percentage",0.0263989503985978
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0263654998820139
"Section II Outpatient Observation Services","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0263289207419459
"Section III Benefit Review","Section M.  Medical Loss Ratio Credibility Adjustment",0.0262211316760218
"Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0261738729133983
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0261627976067091
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Maximum Out of Pocket (MOOP) Limits",0.0261352602256529
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section D.  ESRD Rates",0.0261280274658662
"Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments","Section C.  Part D Risk Sharing",0.0261268844520157
"Section II Part C Optional Supplemental Benefits","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0260284704731244
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0258630300055936
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section D.  Retiree Drug Subsidy Amounts",0.0258069887046255
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Plan Corrections",0.0257067670106569
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section A.  MA Growth Percentage",0.0256917497769354
"Section II Outpatient Observation Services","Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs",0.0256910714737717
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0256396560378603
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Transparency   Timeliness with Prior Authorization Processes",0.0256109749712991
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0254876261544676
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0254823595718813
"Section M.  Medical Loss Ratio Credibility Adjustment","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0254095634395421
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.0253164151315577
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0253004703120028
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Enforcement Actions for Provider Directories",0.0252332591679093
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section D.  Medicare Part D Benefit Parameters  Annual Adjustments for Defined Standard Benefit in 2019",0.025201655788267
"Section B.  FFS Growth Percentage","Section II Tiered Cost Sharing of Medical Benefits",0.0251830859501429
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Enforcement Actions for Provider Directories",0.0251329277201955
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0250171859149879
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0248693644530094
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0248674062185475
"Section D.  Retiree Drug Subsidy Amounts","Section M.  Medical Loss Ratio Credibility Adjustment",0.0248400891462719
"Section II Cost Plan Competition Requirements","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0248379606586416
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0247864222847639
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0247843177275718
"Section II Outpatient Observation Services","Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice",0.0247840798548305
"Section D.  ESRD Rates","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0247627472735618
"Section A.  MA Growth Percentage","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0247015253539362
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Part C Optional Supplemental Benefits",0.0246324015877909
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0245508388710768
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0244386038501399
"Section II Employer Group Waiver Plans","Section C.  Part D Risk Sharing",0.0243661939735862
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0242658571472089
"Section I Enforcement Actions for Provider Directories","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0242582223936813
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0241848106341277
"Section C.  IME Phase Out","Section III CY 2019 Formulary Submission Window",0.0241625322629798
"Section III Benefit Review","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.0240655475555945
"Section D.  Retiree Drug Subsidy Amounts","Section I Plan Corrections",0.0239792908352161
"Section III Benefit Review","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0239621505250665
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Plan Corrections",0.0239602131444257
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0239165334444725
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Parts A and B Cost sharing for Individuals Enrolled in the Qualified Medicare Beneficiary (QMB) Program",0.0238436707222034
"Section II Outpatient Observation Services","Section I Plan Corrections",0.0237699402014186
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Validation Audits",0.0236716789418394
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section D.  Retiree Drug Subsidy Amounts",0.0236096082324943
"Section A.  MA Growth Percentage","Section I Innovations in Health Plan Design",0.0233655914631366
"Section C.  IME Phase Out","Section I Plan Corrections",0.0233249249942697
"Section J.  Frailty Adjustment for PACE organizations and FIDE SNPs","Section III Tier Composition",0.0233207118942423
"Section I Enforcement Actions for Provider Directories","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0230556779858003
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Coordination of Benefits (COB) User Fee",0.0229382200912132
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section L.  Normalization Factors",0.0229123085793477
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Coordination of Benefits (COB) User Fee",0.0228470140835225
"Section III Specialty Tiers","Section II Transparency   Timeliness with Prior Authorization Processes",0.0227474912606601
"Section D.  Retiree Drug Subsidy Amounts","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0227000864239335
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0226764403656632
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Enhancements to the 2019 Star Ratings and Future Measurement Concepts",0.0226509125427652
"Section D.  Retiree Drug Subsidy Amounts","Section B.  FFS Growth Percentage",0.0225891382523899
"Section A.  MA Growth Percentage","Section III CY 2019 Formulary Submission Window",0.02249943321657
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Outpatient Observation Services",0.0224978852981683
"Section III Tier Composition","Section L.  Normalization Factors",0.0224492537080376
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0224196086938067
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0223839712229272
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Specialty Tiers",0.0221609009997865
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section II Transparency   Timeliness with Prior Authorization Processes",0.0221496806830122
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0220932915517764
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)",0.0220192753025272
"Section C.  IME Phase Out","Section III Tier Composition",0.0216409532539181
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs",0.0214559561955645
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0213556941694008
"Section B.  FFS Growth Percentage","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0212407254565845
"Section I Plan Corrections","Section D.  ESRD Rates",0.0212310804547267
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.021211066528285
"Section III Coordination of Benefits (COB) User Fee","Section L.  Normalization Factors",0.0211301863619924
"Section M.  Medical Loss Ratio Credibility Adjustment","Section C.  Part D Risk Sharing",0.0211100165460375
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section C.  Part D Risk Sharing",0.0210451242974327
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.0208616479694303
"Section I Enforcement Actions for Provider Directories","Section C.  Part D Risk Sharing",0.020835678014933
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Tier Composition",0.0208161742895944
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Tiered Cost Sharing of Medical Benefits",0.0208149116155145
"Section III Specialty Tiers","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0207924811348889
"Section I Enforcement Actions for Provider Directories","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0207288824474565
"Section B.  FFS Growth Percentage","Section III Tier Composition",0.0206889205812745
"Section II Outpatient Observation Services","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0206495490395661
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0204624136419454
"Section I Plan Corrections","Section II Maximum Out of Pocket (MOOP) Limits",0.0204408564586783
"Section III Specialty Tiers","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.020371077711738
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0203079701322374
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap",0.0203048301291058
"Section II Outpatient Observation Services","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0202517134687051
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0202241038455229
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Incomplete and Inaccurate Bid Submissions",0.0201574447784905
"Section II Outpatient Observation Services","Section B.  FFS Growth Percentage",0.0201527318816742
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0200142730422323
"Section I Enforcement Actions for Provider Directories","Section D.  ESRD Rates",0.0198984575952176
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0197385508487931
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section M.  Medical Loss Ratio Credibility Adjustment",0.0196567245382544
"Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0196369660357844
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Improving Access to Part D Vaccines",0.0195559278460219
"Section II Part C Optional Supplemental Benefits","Section I Enforcement Actions for Provider Directories",0.0195433777933537
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Improving Access to Part D Vaccines",0.0193727642900272
"Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0193128922066969
"Section H.  Enhanced Medication Therapy Management (MTM) Model","Section M.  Medical Loss Ratio Credibility Adjustment",0.0192109155283846
"Section I Enforcement Actions for Provider Directories","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0191339942536424
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Cost Plan Transition to MA under MACRA",0.0190900887080303
"Section A.  MA Growth Percentage","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0190744004003388
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section F.  Location of Network Areas for PFFS Plans in Plan Year 2020",0.0190153075416611
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section I Enforcement Actions for Provider Directories",0.0189701331026867
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Improving Access to Part D Vaccines",0.0188659657217191
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0188507591090085
"Section III Benefit Review","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0187235059677148
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section H.  Enhanced Medication Therapy Management (MTM) Model",0.0186917928628581
"Section M.  Medical Loss Ratio Credibility Adjustment","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0186858483215392
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Cost Plan Transition to MA under MACRA",0.0186173583979531
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section N.  Encounter Data as a Diagnosis Source for 2019",0.0183796756375296
"Section D.  Retiree Drug Subsidy Amounts","Section I Validation Audits",0.0182136846557138
"Section A.  MA Growth Percentage","Section III Improving Access to Part D Vaccines",0.0180627869959757
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section C.  Part D Risk Sharing",0.0179927493694469
"Section II Outpatient Observation Services","Section III Low Enrollment Plans (Stand alone PDPs only)",0.017924486186732
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Enforcement Actions for Provider Directories",0.0177620547196581
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0177602244406423
"Section II Employer Group Waiver Plans","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0177179440338261
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section C.  Part D Risk Sharing",0.0176132785975484
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Expanding the Part D OTC Program",0.0175344715866014
"Section I Enforcement Actions for Provider Directories","Section III Tier Composition",0.0173335773842123
"Section II Part C Optional Supplemental Benefits","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0173228179387484
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section E.  Clinical Trials",0.0172250947607919
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section M.  Medical Loss Ratio Credibility Adjustment",0.017183303039568
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.016999486481602
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section E.  Reduced Coinsurance for Applicable Beneficiaries in the Coverage Gap",0.0169888272719923
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Health Related Supplemental Benefits",0.0169406381302818
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section D.  Retiree Drug Subsidy Amounts",0.0167859915566148
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section C.  Part D Risk Sharing",0.0166666666666667
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Tiered Cost Sharing of Medical Benefits",0.0166236241057194
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0166032445171996
"Section II Meaningful Difference (Substantially Duplicative Plan Offerings)","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0165330038848761
"Section I Enforcement Actions for Provider Directories","Section I.  ESRD Risk Adjustment Model for CY 2019",0.0164577327021938
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Plans with Low Enrollment",0.0163538903740672
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Medicare Advantage (MA) Segmented Service Area Options",0.0163488345331277
"Section I Enforcement Actions for Provider Directories","Section III Part D Benefit Parameters for Non Defined Standard Plans",0.0163411408167296
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0163101599824434
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.016242243642804
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0161321367316588
"Section B.  FFS Growth Percentage","Section II Cost Plan Transition to MA under MACRA",0.016031400044587
"Section II Outpatient Observation Services","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0158242507320489
"Section III Coordination of Benefits (COB) User Fee","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0157029413924377
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section II Maximum Out of Pocket (MOOP) Limits",0.0156147866340958
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Transparency   Timeliness with Prior Authorization Processes",0.0156076508727692
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section E.  Clinical Trials",0.0155335437648871
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0155305554253273
"Section D.  Retiree Drug Subsidy Amounts","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.015526141254122
"Section I Plan Corrections","Section L.  Normalization Factors",0.0154250281812031
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Tier Composition",0.0153902603022909
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Maximum Out of Pocket (MOOP) Limits",0.0153612697208152
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section M.  Medical Loss Ratio Credibility Adjustment",0.0152896887757233
"Section III Specialty Tiers","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0152313702058001
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section D.  Retiree Drug Subsidy Amounts",0.0151986917529184
"Section A.  MA Growth Percentage","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0151554297660105
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Part C Cost Sharing Standards",0.0151509948772056
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section D.  Retiree Drug Subsidy Amounts",0.0151306883167201
"Section II Part C Optional Supplemental Benefits","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.015095710067927
"Section II Special Needs Plan (SNP) Legislative Sunset Provision","Section E.  Clinical Trials",0.0149682218763944
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section C.  Part D Risk Sharing",0.0147044690731961
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0146290996939042
"Section II Outpatient Observation Services","Section C.  Part D Risk Sharing",0.0145802960879951
"Section I Enforcement Actions for Provider Directories","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0145196233787604
"Section A.  MA Growth Percentage","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0145140467307767
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III CY 2019 Formulary Submission Window",0.0144787030858836
"Section I Annual Calendar","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0144750696332137
"Section A.  MA Growth Percentage","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0143443827637312
"Section A.  MA Growth Percentage","Section B.  Encounter Data as a Diagnosis Source for 2019",0.014300313895335
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0141897511802829
"Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness","Section L.  Normalization Factors",0.0140131896765426
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0138912709983119
"Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0136674351612183
"Section II Employer Group Waiver Plans","Section M.  Medical Loss Ratio Credibility Adjustment",0.013579388009784
"Section III Specialty Tiers","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0135159819606094
"Section D.  Retiree Drug Subsidy Amounts","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0.0133440128170906
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Part D Mail Order Refill Consent Policy  Solicitation for Comments",0.0133134715282956
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section A.  MA Growth Percentage",0.0130869987174824
"Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0127944434864228
"Section III Timely Updates to LIS Status Based on Best Available Evidence","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0126325027985295
"Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)","Section D.  Retiree Drug Subsidy Amounts",0.0126242233711467
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0125623531139501
"Section II Overview of CY 2019 Benefits and Bid Review","Section B.  Encounter Data as a Diagnosis Source for 2019",0.012097498050936
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section K.  Medicare Advantage Coding Pattern Adjustment",0.0120385853085769
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section I Enforcement Actions for Provider Directories",0.0119312827960033
"Section D.  Retiree Drug Subsidy Amounts","Section II Transparency   Timeliness with Prior Authorization Processes",0.0119205402574847
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.0118885559222531
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.0118719975990074
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.0118523256756357
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section I Enforcement Actions for Provider Directories",0.0117883880269308
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Expanding the Part D OTC Program",0.0117363131703255
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section A.  MA Growth Percentage",0.0116051770637132
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section M.  Medical Loss Ratio Credibility Adjustment",0.0114908375554449
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Per Member Per Month (PMPM) Actuarial Equivalent (AE) Cost Sharing Limits",0.0114593660019725
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.0114331493380927
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Maximum Out of Pocket (MOOP) Limits",0.0114241425175238
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section III Tier Composition",0.0113808146063157
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Cost Plan Transition to MA under MACRA",0.011189434999828
"Section A.  MA Growth Percentage","Section I Enforcement Actions for Provider Directories",0.0107373361530655
"Section III Medication Therapy Management (MTM) Annual Cost Threshold","Section B.  Encounter Data as a Diagnosis Source for 2019",0.0105936324568514
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section III Low Enrollment Plans (Stand alone PDPs only)",0.0105223815623263
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.0103518614870573
"Section N.  Encounter Data as a Diagnosis Source for 2019","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.0102754791342852
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Timely Updates to LIS Status Based on Best Available Evidence",0.0102516932710555
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.0101223337686118
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0.00994987934600712
"Section A.  MA Growth Percentage","Section III Coordination of Benefits (COB) User Fee",0.00976074387511493
"Section D.  Retiree Drug Subsidy Amounts","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.00964417464678889
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section II Outpatient Observation Services",0.00963142660661774
"Section A.  Update of the RxHCC Model","Section I Audit of the Sponsoring Organization s Compliance Program Effectiveness",0.00942387188682406
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.00934175633663747
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section II Special Needs Plan (SNP) Legislative Sunset Provision",0.00925985469087039
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Special Needs Plan (SNP) Specific Networks Research and Development",0.00922963334579222
"Section I Enforcement Actions for Provider Directories","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.00917481625127662
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.00909737258912407
"Section D.  Retiree Drug Subsidy Amounts","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00886867819275126
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Plans with Low Enrollment",0.00884384539356461
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.00872564472287819
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section III Medication Therapy Management (MTM) Annual Cost Threshold",0.00859708264514137
"Section II Transparency   Timeliness with Prior Authorization Processes","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00824611596333474
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Improving Access to Part D Vaccines",0.00821247899087755
"Section II Medicare Advantage (MA) Segmented Service Area Options","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00818833591663431
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Improving Beneficiary Communications and Reducing Burden for Integrated D SNPs",0.00816385560040468
"Section M.  Medical Loss Ratio Credibility Adjustment","Section III Tier Composition",0.00798263844093184
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)",0.00774984258292129
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Advantage (MA) Uniformity Flexibility",0.00762011209000621
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section III Using the Best Available Information when making B vs D Coverage Determinations for Immunosuppressants and Inhalation Durable Medical Equipment (DME) Supply Drugs",0.0074252740055558
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section D.  Retiree Drug Subsidy Amounts",0.00704924890729689
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Maximum Out of Pocket (MOOP) Limits",0.00703861832907539
"Section II Encounter Data Listening Forums  Monitoring and Compliance Activities","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.00698513710669905
"Section F.  Dispensing Fees and Vaccine Administration Fees for Applicable Drugs in the Coverage Gap","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00697783868682219
"Section A.  MA Growth Percentage","Section D.  Retiree Drug Subsidy Amounts",0.00689081858828936
"Section I Enforcement Actions for Provider Directories","Section L.  Normalization Factors",0.00680321740513372
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section I Innovations in Health Plan Design",0.00668270584546028
"Section I Plan Finder Civil Money Penalty (CMP) Icon or Other Type of Notice","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.00624913551467991
"Section III Benefit Review","Section K.  Medicare Advantage Coding Pattern Adjustment",0.00623055982849033
"Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00615387528468568
"Section A.  MA Growth Percentage","Section II Outpatient Observation Services",0.00614759261302765
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Health Related Supplemental Benefits",0.00602223903544489
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Rewards and Incentives for Completion of a Health Risk Assessment (HRA)",0.00550966277983909
"Section III LIS Enrollee Cost sharing for Out of Network Part D Drugs","Section B.  Encounter Data as a Diagnosis Source for 2019",0.00537312235884078
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section II Medicare Diabetes Prevention Program (MDPP) Services Clarification",0.00534801417304785
"Section A.  MA Growth Percentage","Section III Tier Composition",0.00531465854523686
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Cost Plan Transition to MA under MACRA",0.00529463797615072
"Section I Enforcement Actions for Provider Directories","Section D.  Retiree Drug Subsidy Amounts",0.00499425989977724
"Section I New Medicare Card Project (formerly the Social Security Number Removal Initiative  SSNRI)","Section M.  Medical Loss Ratio Credibility Adjustment",0.00490797915463962
"Section III Specialty Tiers","Section M.  Medical Loss Ratio Credibility Adjustment",0.00474013508250224
"Section K.  Medicare Advantage Coding Pattern Adjustment","Section I Enforcement Actions for Provider Directories",0.00459858826615488
"Section II Special Needs Plan (SNP) Specific Networks Research and Development","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.00369999414938888
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Encounter Data Listening Forums  Monitoring and Compliance Activities",0.0029040701039833
"Section I Plan Corrections","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0.00279693267762198
"Section B.  Encounter Data as a Diagnosis Source for 2019","Section III Expanding the Part D OTC Program",0.00241031741535402
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section E.  Estimated Total Covered Part D Spending at Out of Pocket Threshold for Applicable Beneficiaries",0
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section B.  Encounter Data as a Diagnosis Source for 2019",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Enhanced Disease Management (EDM) for Dual Eligible Special Needs Plans (D SNPs) and Institutional Special Needs Plans (I SNPs)",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Cost Plan Competition Requirements",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Medicare Advantage (MA) Segmented Service Area Options",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section I Enforcement Actions for Provider Directories",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section II Outpatient Observation Services",0
"Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount","Section A.  MA Growth Percentage",0
"Section II Coverage of Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0
"Section H.  CMS HCC Risk Adjustment Model for CY 2019","Section G.  Part D Calendar Year Employer Group Waiver Plans Prospective Reinsurance Payment Amount",0
